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Speaking at the launch, Minister for Drugs John Curran TD announced:
The extension of the ‘Dial to Stop Drug Dealing’ campaign. Minister Curran said he had • 
decided to continue the scheme owing to the positive outcomes being achieved. He noted 
that an emphasis on the evaluation of outcomes and the allocation of resources based on 
evidence of real achievement would be a feature of the new Strategy.
The allocation of capital funding of • €1.1 million towards the development of treatment 
clinics in Limerick, Cork, Waterford, Enniscorthy, Drogheda and Dundalk. The Minister said 
he had been assured that some of these clinics would be in operation by the end of the year, 
with treatment being available in all six locations early in 2010.
The HSE and the Irish Pharmacy Union have agreed a plan to roll out needle exchange • 
services through community pharmacies in 65 new locations. Implementation of this 
initiative, which is supported by the Elton John AIDS Foundation, will commence shortly.
On 10 September 2009 the Irish government published its national drugs strategy 2009–2016.1 
Noting that the previous drugs strategy had been successful in tackling the heroin problem in 
Dublin, the Taoiseach, Brian Cowen TD, acknowledges in his foreword to the new strategy that the 
situation has now changed: ‘problem drug use has spread to other areas and the range of drugs 
available has increased. The challenge involved is complicated by the fact that drug use can be 
linked to circumstances of social exclusion as well as to circumstances of economic prosperity.’ 
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Figure 1 Framework of National Drugs Strategy 2009–2016
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One overall strategic objective
Five overall strategic aims 
New drugs strategy published
Both the Taoiseach and the Minister for Drugs, John Curran TD, emphasise that partnership both 
at national and local level, including the drugs task forces, will continue to form the basis of the 
government’s approach to tackling the problem. Minister Curran confi rms that the government will 
retain the fi ve pillars – supply reduction, prevention, treatment, rehabilitation and research, ‘as these 
have served us well and still encompass the areas that need to be addressed. This will also facilitate 
the dovetailing of the Strategy with the provisions of the EU Drugs Action Plan 2009–2013.’
Overall strategic objective
To continue to tackle the harm caused to individuals and society by the misuse of drugs through 
a concerted focus on the fi ve pillars of supply reduction, prevention, treatment, rehabilitation, 
and research.
Overall strategic aims
To create a safer society through the reduction of the supply and availability of drugs • 
for illicit use;
To minimise problem drug use throughout society;• 
To provide appropriate and timely substance treatment and rehabilitation services • 
(including harm reduction services) tailored to individual needs;
To ensure the availability of accurate, timely, relevant and comparable data on the • 
extent and nature of problem substance use in Ireland; and
To have in place an effi cient and effective framework for implementing the • 
National Substance Misuse Strategy 2009–2016.
The new strategy uses the same framework as before, constructed around a hierarchy of aims, 
objectives, key performance indicators and actions (Figure 1). The pillar construction is accompanied by 
a co-ordination ‘pillar’, with its own objectives, KPIs and actions. The expectation appears to be that the 
high-level aspirations will provide an over-arching logic uniting the whole, while, simultaneously, the 
underpinning actions will drive the new strategy forward.
While the overall strategic approach and framework are the same as before, the contents of the pillars 
in the NDS 2009–2016 reveal some shifts in emphasis – refl ecting either the changing nature of the 
situation and the problem being faced, the experience gained through implementing the previous 
drugs strategy, or the insights acquired through the new research and information accumulated 
during the past seven years. While the overall strategic objective remains broadly the same, there has 
been a change in the active verb – ‘to signifi cantly reduce the harm’ in the previous strategy has been 
replaced by ‘to continue to tackle the harm’. 
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More details on policy initiatives under each of the pillars 
may be found in the sections below. 
Although there was no fi nal evaluation of the previous drugs 
strategy, the Steering Group that drew up the new strategy 
assessed progress under each of the pillars. A summary of this 
assessment is provided on page 8. Furthermore, aware that a 
combined substance misuse strategy, including both alcohol 
and illicit drugs, was to be developed over the next 18 
months to two years, the Steering Group initiated discussion 
of alcohol misuse under each of the pillars in the new 
‘interim’ strategy. This discussion is summarised on page 9.
Supply reduction pillar
Under the supply reduction pillar, the primary aim of 
reducing the availability of drugs remains. However, there 
is a greater note of realism evident in the NDS 2009–2016, 
for example in the way in which the impact of drug supply 
reduction activities is determined. 
Acknowledging the signifi cant increase in drug seizures 
in recent years, the Steering Group states that during the 
consultation phase ‘the impact of those seizures on reducing 
the overall supply of drugs was questioned’ (para. 2.22).
It goes on to state, ‘Due to the problems associated with 
estimating the size of the illegal drug market in Ireland, it is 
diffi cult to conclude whether increased seizures are actually 
resulting in a reduction in overall supply – or whether the 
overall supply of drugs has increased and the percentage 
of seizures has remained relatively even.’ (para. 2.27) The 
Steering Group further acknowledges that ‘the fi gures 
often quoted in relation to drugs seizures as a percentage 
of the total drugs market in Ireland are speculative and 
currently, have no proven basis’ (para. 2.27). Consequently, 
the Group concludes that there is a need to develop other 
measurements to determine the effectiveness of supply 
reduction activities rather than relying on drug seizures. 
An issue highlighted during the consultation phase was the 
possibility of decriminalising or changing the legal status of 
cases of simple possession of certain drugs, such as cannabis, 
owing to the Garda resources involved in prosecuting 
such cases. The Steering Group reports that, according to 
the gardaí, ‘about 20% of drugs crime relates to supply 
offences and 80% to possession’ (para. 2.29). Despite this, 
most members of the Group are not in favour of ‘legalising, 
decriminalising, or changing/redefi ning the legal status 
of certain illicit drugs (cannabis was the focus of most 
discussion in this context)’ (para. 2.49). The Steering Group 
notes that the fi ndings of the nationwide drug prevalence 
surveys conducted in 2002/03 and 2006/07 indicated that 
approximately 70% of respondents did not think recreational 
cannabis use should be permitted (support for the medicinal 
use of cannabis was about 70%). The Group does, however, 
identify as a priority the ongoing monitoring of legislative 
and regulatory frameworks with a view to pursuing changes 
where necessary. 
Other priorities identifi ed by the Steering Group include 
developing local partnership approaches through the joint 
policing committees and local policing fora provided for in 
the Garda Síochána Act 2005; tackling underage drinking 
and drug-related intimidation; the development of an 
integrated system to track the progression of offenders with 
drug-related offences through the criminal justice system; 
the continued implementation of measures to curtail the 
supply of drugs into Irish prisons; and a renewed focus 
on addressing the use of precursors in the manufacture of 
illicit synthetic drugs. The last priority calls for increased 
collaboration with international bodies such as the EMCDDA 
and the Pompidou Group of the Council of Europe. 
Prevention pillar
In their forewords to the new drugs strategy both the 
Taoiseach and the Minister for Drugs emphasised the 
importance of prevention. Minister Curran stated: ‘If we 
could achieve more in regard to prevention, I believe 
that the impact on the overall problem would be greatly 
enhanced.’ 
Having reviewed progress under the previous drugs 
strategy, the Steering Group concluded that ‘a tiered or 
graduated approach to prevention and education measures 
in relation to drugs and alcohol should be developed with 
a view to providing a framework for the future design and 
development of interventions’ (para. 3.56). The Steering 
Group identifi es three levels in this framework, which are 
outlined in the following table. In naming the three levels, 
the Group combined the current prevention classifi cation 
framework – universal, selected and indicative – with the old 
classifi catory framework of primary, secondary and tertiary. 
Universal (primary) prevention programmes
Aimed at reaching the general population, such as students 
in schools, to promote overall health of the population and 
to prevent the onset of drug and alcohol misuse. Measures 
often associated with this type of programme include 
awareness campaigns, school drug/alcohol education 
programmes and multi-component community initiatives.
Selected (secondary) prevention programmes
Aimed at groups at risk, as well as subsets of the general 
population including children of drug users, early school 
leavers and those involved in anti-social behaviour. These 
programmes aim to reduce the effect of risk factors present 
in these subgroups by building on strengths and developing 
resilience and protective factors.
Indicative (tertiary) prevention programmes
Targeted at people who have already started using 
drugs/alcohol, or who are likely/vulnerable to engage in 
problematic drug/alcohol use (but may not necessarily 
be drug/alcohol dependent), or to prevent relapse. These 
require individual or small group programmes aimed at 
addressing specifi c needs.
With regard to specifi c interventions, the Steering Group 
identifi es the following priorities: 
improved delivery of SPHE in primary and post-primary • 
schools – the Steering Group acknowledges that 
while the focus of prevention measures in the 
previous strategy had been on the provision of 
education services in school settings for the school-
going population, their application and delivery had 
limited their effectiveness.
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the co-ordination of the activities and funding of • 
youth interventions in out-of-school settings to 
optimise their impacts – under the previous strategy 
the provision of education in non-school settings 
had been fragmented, the provision of alternative 
recreational facilities for young people had been 
under-developed, and many young people had not 
had access to recreational facilities in out-of-
school settings.
a continued focus on orienting educational and • 
youth services towards early interventions for 
people and communities most at risk – the Steering 
Group recommends that actions be developed to 
further support the families of drugs users, and 
it acknowledged community development as an 
important step in building the capacity of local 
communities to avoid, or respond to and cope with, 
drug problems. 
the development of timely awareness campaigns • 
targeted in a way that takes individual social and 
environmental conditions into account – the Steering 
Group sees a need to further develop and promote 
prevention strategies in a number of key areas such 
as third-level institutions, workplaces, sports and 
other community and voluntary organisations.
Treatment and Rehabilitation pillars
The Steering Group states that this pillar, which combines 
the treatment and rehabilitation pillars, has a wider focus 
than in the previous strategy. It aims to develop a more 
comprehensive treatment service capable of dealing with all 
problem substances nationally, rather than focusing mainly 
on opiate misuse in Dublin. The Group identifi es a number 
of priorities, grouped under four main themes.
Development of general problem substance use services – 1. 
develop an integrated national treatment and rehabilitation 
service for all substances, using a four-tier model approach, 
underpinned by an appropriate clinical governance regime.
The Steering Group supports the HSE’s reorientation of 
addiction services towards polydrug use using a four-tiered 
model approach. The focus of the strategy will be on 
the development of addiction services, and of pathways 
between them and other relevant health and social services.
The treatment of drug users with hepatitis C is specifi cally 
mentioned for the fi rst time in the new strategy. The Group 
notes that there has been a gradual and consistent decrease 
in the number of HIV cases reported, while the incidence 
of hepatitis C among injecting drug users (IDUs) remains 
a cause of concern. The KPI on the monitoring of the 
incidence of HIV has been dropped and, for the fi rst time, a 
KPI for the treatment of hepatitis C in drug users has been 
included. 
Data from the National Drug-Related Deaths Index 
(NDRDI),2 set up in line with Action 67 in the NDS 2001–
2008, show an increase in drug-related deaths since 1998, 
and a new action in the NDS 2009–2016 calls for the 
development of a National Overdose Prevention Strategy, 
and also for a response to the increasing numbers of 
indirectly drug-related deaths. 
The Steering Group prioritises the expansion of the 
availability of detox facilities, opiate substitution services, 
under-18 services and needle-exchange services where 
required. The KPI relating to provision of services for under-
18s remains the same as in the previous strategy, but with 
a new target of 100% access to treatment within one week 
(as opposed to one month) of assessment by 2012. While 
the document states that methadone substitution is the 
cornerstone of opiate treatment and looks for continued 
recruitment of Level two GPs, a new action calls for the 
review of the Methadone Treatment Protocol to maximise 
the provision of treatment and facilitate appropriate 
progression pathways. Additionally, the action calls for 
alternative opiate substitution services.
Noting that there was only a small increase in the number 
of residential places between 2001 and 2006, the Steering 
Group calls for the development of residential care in the 
context of the four-tier model. Along with appropriate 
aftercare services, the Group sees residential care as central 
to the provision of alternative, drug-free treatment for 
problem drug users. The NDS 2009–2016 includes a new 
KPI relating to residential places, which states that there 
should be a 25% increase in residential rehabilitation places 
by 2012 based on 2008 fi gures. 
The Steering Group calls for the establishment of a drugs 
intervention programme aimed at young people and young 
adults, incorporating a treatment referral option, for those 
who come to the attention of the Garda Síochána because 
of behaviour caused by substance misuse. While many of 
the services needed for this programme are already in place, 
the Group notes that interagency co-ordination needs to be 
developed. A new KPI specifi es that this programme should 
be in place by 2012.
Specifi c groups – further develop engagement with, 2. 
and the provision of services for specifi c groups: prisoners, 
homeless, Travellers, new communities, the lesbian, 
gay, bisexual and transgender (LGBT) community and 
sex workers.
These specifi c groups are listed separately in the NDS 
2009–2016. Those with a dual diagnosis (both mental 
health and substance misuse problems) are also mentioned 
specifi cally. These groups have been highlighted in order 
to differentiate their specifi c needs and to tailor services for 
them. New issues for prisoners have also been identifi ed. 
These include the recognition of the high risk of overdose or 
relapse immediately following release from custody and the 
need for the development of an effective and co-ordinated 
interagency approach to ensure a seamless transition from 
prison back into the community. The Steering Group notes 
that not all prisons provide substitution treatment, and 
identifi es this issue as a key gap. 
Quality and standards framework – develop a clinical and 3. 
organisational governance framework for all treatment and 
rehabilitation services. 
The Steering Group states that while progress has 
been made in introducing standards in treatment and 
rehabilitation services, further measures are necessary. For 
example, currently neither counselling nor psychotherapy 
services are statutorily regulated. New actions are identifi ed 
in relation to developing a clinical and organisational 
governance framework for addiction services and developing 
a regulatory framework on a statutory basis for the provision 
of counselling. 
drugnet 
IRELAND
5New drugs strategy published  (continued)
Training and skills development – develop national training 4. 
standards for all those involved in the provision of substance 
misuse services, and co-ordinate training provision within a 
single national substance misuse framework.
The actions relating to training and skills development are 
more specifi c in the new strategy, as they are seen as a 
key component in the development of a comprehensive 
addiction service. The new actions call for the development 
of national training standards, including accreditation, for 
addiction services (both statutory and voluntary). The need 
for staff training in the use of naloxone in order to prevent 
fatal overdose is specifi cally mentioned. 
Research and information pillar
The NDS 2009–2016 intends to collect information and 
complete research projects in order to inform policy 
formulation and to develop or enhance responses to the 
drug situation, while the NDS 2001–2008 intended to 
measure the extent of drug use by person, place and time, 
and describe the characteristics of drug users, but did not 
state how the new information would be used (Table 1). 
Table 1 Research objectives, NDS 2001–2008, and research and information objectives, NDS 2009–2016
2001–2008 2009–2016
Have valid, timely and comparable data on the extent of drug 
misuse amongst the Irish population and specifi cally amongst all 
marginalised groups.
Ensure the availability of data to accurately inform 
decisions on initiatives to tackle problem substance use.
Gain a greater understanding of the factors which contribute 
to Irish people, particularly young people, misusing drugs.
Provide appropriate research to fulfi l the information 
needs of the government in formulating policies to 
address problem substance use. 
The NDS 2001–2008 was based on a low level of 
information and the information that existed was not 
collated in a single place or easy to access. The NDS 2001–
2008 intended to eliminate all research gaps and funded an 
extensive programme of research on the drug situation and 
the responses to it (Table 2). 
The NACD was established to co-ordinate the programme 
of research and advise the government on its fi ndings. The 
information available on the drug situation has increased 
dramatically since 2001; for example, the NACD published 
70 research reports between 2001 and 2008, and the HRB 
published 35 reports during the same period. All research 
publications are located in a single web-based library known 
as the National Documentation Centre on Drug Use (NDC). 
At the time the NDS 2001–2008 was developed, it was not 
widely understood by those working in the drugs area that 
the EMCDDA required all countries to complete an annual 
national report on the current drug situation and responses 
to it. Since 2004, these national reports to the EMCDDA 
have been made available on the NDC website and are used 
by policy makers to keep abreast of progress. 
Table 2 Research KPIs, NDS 2001–2008, and research and information KPIs, NDS 2009–2016
2001–2008 2009–2016
Eliminate all major research gaps in drug research by end 
2003.
EMCDDA indicators developed on the extent and nature 
of problem drug use in Ireland
Publish an annual report on the nature and extent of the drug 
problem in Ireland and on progress being made in achieving 
the objectives set out in the Strategy.
Comprehensive and timely reporting systems in place for: 
treatment, rehabilitation, and the progression of offenders 
(with drug-related offences) through the criminal justice 
system
Completion of identifi ed research programme each year 
by the NACD
The challenge now is to sustain this level of knowledge 
and to identify the most effi cient ways of updating our 
knowledge. With this in mind, the title of the research pillar 
has being changed to the research and information pillar. In 
the NDS 2009–2016 the emphasis, and investment, will be 
on the development of a single information system that will 
consist of existing data sources (such as the CTL, NDTRS, 
NDRDI, and HPSC) and these sources will be linked using a 
unique identifi er. This will allow services to document the 
exact number of known problem drug users, and to trace 
their treatment and rehabilitation pathways and outcomes. 
Consent and data-protection procedures will be put in place 
to protect individuals’ identities. 
The EMCDDA indicators will guide the continuous and 
periodic data-collection process. Examples of continuous 
data-collection processes are the CTL, HPSC drug-related 
infectious diseases, NDTRS, NDRDI and PULSE. Examples of 
periodic data collection processes are the survey measuring 
the prevalence of problem drug use among the general 
population and the estimation of the numbers of problem 
drug users. 
The Minister of State, the OMD and the NACD will develop 
and prioritise a research programme, revised on an annual 
basis. The programme will include projects that could not be 
achieved through routine data-collection mechanisms, for 
example exploring new issues, testing new interventions or 
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Table 3 Research and information priorities, NDS 2009–2016
Continue to develop indicators and reporting systems on the extent and nature of problem substance use in Ireland 
(seeking to remove barriers to the development of these reporting systems and indicators).
Develop a prioritised research programme, to be reviewed annually.
Continue the drug prevalence and the ESPAD surveys.
Develop a research management framework and disseminate research fi ndings and models of best practice.
Figure 2 Co-ordination arrangements for the NDS 2009–2016 (after NDS 2009–2016, Table 6.4) 
  
    
             National Advisory
Committee on
Drugs (NACD)
Drugs Task Forces (DTFs)
Oversight Forum on Drugs
(OFD)
Minister/Office of the Minister
for Drugs (OMD)
Government
Statutory Agencies
Cabinet Committee on Social Inclusion,
Children and Integration (CCSCI)
Assessing progress under the NDS 2001–2008, the Steering 
Group that drafted the new NDS found that 20 out of 22 
actions to support co-ordination had been implemented, 
the key performance indicators relating to co-ordination 
reached, and that the co-ordination arrangements had 
‘stimulated and promoted inter-agency working in a diffi cult 
cross-cutting policy and service area’ (para. 6.7). However, 
the Steering Group also found that there were ‘capacity and 
structural limitations’, which were limiting ability to meet the 
new challenges, including: 
accounting for expenditure;• 
governance;• 
mainstreaming;• 
capacity of services to meet client needs; and• 
monitoring/evaluation. • 
measuring long-term impact. The development of an annual 
rather than an eight-year research programme will allow for 
sudden changes in the situation and prioritising of projects 
in line with available resources. 
The seven research-related actions of the NDS 2001–2008 
were substantially completed. In the NDS 2009–2016 four 
priorities have been identifi ed which closely link to the key 
performance indicators (Table 3). These priorities have been 
translated into eight associated actions which identify the 
agency with lead responsibility for implementation, together 
with all other contributing agencies. 
The critical success factors for Ireland in delivering on the 
new strategic objectives are that capacity to complete 
drug-related research is developed further, that there is not 
duplication of research projects or information systems, and 
that projects and interventions are planned using the best 
practice available within Ireland or in other countries.
Co-ordination pillar
Compared to the co-ordination arrangements in place 
for the previous drugs strategy, those to support the 
implementation of the NDS 2009–2016 have been 
signifi cantly simplifi ed and streamlined (see Figure 2). A 
new Offi ce of the Minister for Drugs (OMD) will incorporate 
the work and functions of both the Drugs Strategy Unit 
(DSU) in DCRGA and the National Drugs Strategy Team 
(NDST) and will report directly to the Cabinet Committee 
on Social Inclusion, Children and Integration (CCSICI) (see 
Table 4). The direct reporting line to the CCSICI and use 
of a ‘networked organisational’ structure in the OMD will 
preclude the need for an Interdepartmental Group on Drugs 
(IDG), which will be reconstituted as an Oversight Forum on 
Drugs (OFD). 
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Responsibilities Operating principles Resourcing
national co-ordination ■
policy development ■
supporting the work of drugs task  ■
forces
supporting the work of the NACD ■
supporting the community and  ■
voluntary sectors
co-ordinating Ireland’s input to the  ■
EU, UN and other international for a 
regarding the drugs issue
local responses to local need, based on  ■
local planning and decision making
community representation and  ■
involvement
partnership between community,  ■
voluntary and statutory sectors
direct linkages between local and  ■
national structures 
direct linkages between local and  ■
national policy
The OMD will be staffed by the current 
staff of the DSU and NDST. Some 12 
offi cers at Assistant Principal level from 
the various government departments 
and state agencies with responsibilities 
under the NDS will also be assigned 
on a half-time basis for a minimum of 
three years. These staff will work with 
the OMD, and protocols to refl ect 
their ongoing roles will be drawn up. 
These staff will also continue to work 
within their parent departments and 
agencies to seek to positively infl uence 
policy, programme activity and resource 
allocation in regard to drug issues.
New drugs strategy published  (continued)
The need was identifi ed to establish a structure which would: 
support and drive the ongoing implementation of • 
the NDS, while respecting the various lead roles 
and statutory responsibilities of the Departments/
agencies involved;
provide a more cohesive and integrated framework • 
that promotes closer co-operation and accountability 
between the different players, as well as greater 
transparency for expenditure;
provide a clear hierarchy and a greater transparency • 
of the roles from the government and the Cabinet 
Committee on Social Inclusion, Children and 
Integration to the local project level.
The design of the OMD resembles the networking model 
promoted in a recent OECD review of the Irish public sector.3 
The OECD review described the Offi ce of the Minister 
for Children and Youth Affairs (OMCYA), established in 
2005, where staff from different government departments 
(including Health, Education and Justice) had been brought 
together in one location (the Department of Health and 
Children) to work in a networked way on issues of strategic 
national importance with regard to children. The review’s 
observations on the OMCYA may be applied equally to the 
new OMD:
Policies that cut across the function responsibility of 
a number of departments can lead to diffi culties in 
determining who is the overarching ‘owner’ accountable 
for the service provided. The work to date by the OMC 
has demonstrated that there is value in ensuring that 
units, such as the Irish Youth Justice Services, remain 
connected to their parent department (Department 
of Justice, Equality and Law Reform). This ensures 
that they have ongoing interaction with, and input 
to the development of policies targeted at children 
while also ensuring that accountability for the services 
they deliver remains within the remit of their Minister. 
This guarantees that historical mismatches between 
children’s policy and youth justice policy can be 
addressed. (pp. 241–242) 
To support integration, the Steering Group recommends 
an Oversight Forum on Drugs (OFD) to replace the 
Interdepartmental Group on Drugs (IDG). Comprising the 
same membership, its primary role will be the high-level 
monitoring of progress being achieved across the strategy 
and agreeing appropriate ways forward where issues are 
blocked or progress is being impeded. It will also provide 
a forum for discussion and feedback on issues relating to 
problem drug use that arise in EU and international arenas. 
The Group proposes two additional mechanisms to support 
the new integrative role of the OMD: (1) an Advisory Group 
of the OMD, comprising representatives of the statutory, 
voluntary and community sectors, to advise the Minister 
on operational and policy matters relating to the NDS; and 
(2) twice-yearly bilateral meetings between the Minister for 
Drugs and the ministers for Justice, Education and Health; 
the Minister and the Director of the OMD and the heads 
of various departments and state agencies involved in 
implementing the NDS; the Minister and the Director of 
the OMD and the chairs and co-ordinators of the DTFs; the 
Minister and the Director of the OMD and the NACD and 
the Family Support Network. The Steering Group believes 
these meetings would help to keep a focus on drug-related 
issues and the broader implementation of the NDS. 
This multiplicity of mechanisms raises the question as 
to whether there is a more effi cient and effective means 
of integrating effort across the statutory, voluntary and 
community sectors and engaging all stakeholders in the 
deliberation over and choice of policy options. For example, 
a study of whole-of-government approaches to cross-cutting 
policy issues in Ireland in the 21st century4 described how 
social partnership can perform such an integrating function. 
Advisory groups such as the National Economic and Social 
Council (NESC) or the National Economic and Social Forum 
(NESF), with broad-based representation of all the social 
partners and reporting to the Department of the Taoiseach, 
have played and continue to play a critical role in supporting 
the development and implementation of key national policies.5 
The National Advisory Committee on Drugs (NACD) is to 
be co-located with the OMD and the Director of the NACD 
is to become a member of the senior management team in 
the OMD. While acknowledging the need for the NACD to 
be ‘independent’ in regard to research, the Steering Group 
states that the closer alignment with the OMD will ‘better 
address the issue of linkages between policy development 
and research’.
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to the OMD for all activities, outputs and expenditures. 
Priorities for the new OMD with regard to the DTFs will 
include:
considering reporting and accountability arrangements  ■
for DTF projects with a view to simplifying the system;
examining the feasibility of achieving the optimum  ■
structure for the employment arrangements of 
DTF personnel;
reviewing and renewing the commitment and  ■
participation of all members of DTFs, including the 
position of chairperson;
updating the handbook for the operation of DTFs to take  ■
account of the new structural arrangements and include 
guidelines on mainstreaming.
The NDS notes that the National Drugs Rehabilitation 
Implementation Committee will also be ‘closely linked’ to 
the OMD. 
New drugs strategy published  (continued)
Steering Group’s assessment of the 
National Drugs Strategy 2001–2008 
The Steering Group that managed the preparation of the 
NDS 2009–2016 assessed the progress that had been made 
against the key performance indicators (KPIs) under each 
of the pillars of the 2001–2008 strategy: supply reduction, 
prevention, treatment, rehabilitation and research.6 The 
Group’s assessment, as reported in the new strategy 
document, is summarised below.
Supply reduction 
All KPIs under this pillar were achieved. The targets of a 
50% increase in volume of drugs seized based on 2000 
fi gures and a 20% increase in the number of seizures based 
on 2004 fi gures were both exceeded. The 125% increase 
in supply detections between 2004 and 2008 signifi cantly 
exceeded the target of 20%. While acknowledging 
the operational success which this represented for law 
enforcement, the Steering Group notes that, without a 
reliable estimate of the size of the illegal drug market in 
Ireland, the impact of increased seizures on the overall 
supply could not be measured.
Other areas of progress included increases in the Garda 
Síochána resources in LDTF areas and various initiatives 
aimed at reducing the supply of drugs, such as the ‘Dial 
to Stop Drug Dealing’ scheme, undertaken by local and 
regional DTFs. Less progress was achieved in expanding 
community policing fora (CPFs) and reducing the availability 
of drugs in prisons. 
Prevention 
The KPIs under this pillar related to levels of problem drug 
use, prevalence, substance use policies in schools and 
rates of early school leaving. Heroin use stabilised in the 
Dublin area, with a signifi cant drop in new entrants, but 
rose substantially outside Dublin. Drug prevalence targets 
were not achieved and the 2006/07 drug prevalence survey 
reported increases in recent and current use. The target 
of having substance use policies in all schools was near 
completion at the time of a Department of Education and 
Science survey in 2005. A number of data sources were 
used to estimate the levels of early school leaving and, while 
precise fi gures were not available, it appeared that early 
school leaving had decreased during the period of the 
NDS 2001–2008.
While many of the actions relating to the implementation 
of prevention programmes were completed or near 
completion, the Steering Group questions the effectiveness 
of a number of the programmes. Despite the high number 
of schools which reported that they had implemented 
substance misuse policies, the quality of these policies had 
not been assessed and there was a need to determine how 
actively they were being implemented. The Social Personal 
Health Education (SPHE) programme, the foundation for 
developing awareness of drugs and alcohol issues in schools, 
is a mandatory part of the curriculum but its effectiveness 
as a drug prevention measure was consistently questioned 
during the consultation process.
Treatment and rehabilitation 
Three of the KPIs under this pillar specifi ed increased 
availability of treatment and harm reduction services, and 
one sought a reduction in the incidence of HIV. The target 
of a maximum waiting period of one month for treatment 
for problem drug use was achieved for almost all non-opiate 
addiction cases. However, there wwere still diffi culties in 
many areas in providing access to methadone treatment 
within one month of assessment. No under-18s had had to 
wait longer than one month to initiate treatment following 
assessment, but there were still not enough residential 
places or community supports. There was limited progress in 
providing harm-reduction services, but the incidence of HIV 
among injecting drug users had seen a consistent reduction. 
The incidence of hepatitis C continued to cause concern. 
While rehabilitation was covered under the treatment 
pillar in the NDS 2001–2008, the mid-term review (MTR) 
of the strategy recommended that a separate pillar be 
established.7 Following a recommendation in the report 
of the Working Group on drugs rehabilitation,8 a National 
Drug Rehabilitation Implementation Committee (NDRIC), 
chaired by the HSE, was set up. The Steering Group notes 
that there was progress in several areas related to the MTR’s 
recommendation to strengthen support for families, 
and that the HSE had signifi cantly developed its family 
support services.
Research
The KPIs under this pillar dealt with information on 
prevalence in the general population, problem drug use, 
demand for drug treatment, drug-related deaths and drug-
related infectious diseases. In 2005 the NACD published 
the fi ndings of a drug prevalence survey carried out in 
Ireland and Northern Ireland in 2002/03. This survey was 
repeated in 2006/07 and the results published in 2008. 
The NACD also commissioned studies on drug prevalence 
among vulnerable groups, including the homeless, new 
communities in Ireland and Travellers. Other studies give 
some insight into alcohol and cannabis use among the youth 
and school-going populations. While work on the second 
3-source capture-recapture study to estimate the prevalence 
of problematic opiate use has yet to be completed, the 
Research Outcome Study in Ireland (ROSIE) and the 
information reported by the NDTRS provide signifi cant 
insights into the patterns of problem drug use.
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Drug Misuse Research Division (renamed Alcohol and Drug 
Research Unit (ADRU) in 2007) increased the effi ciency of 
the fl ow of this data and the quality of the information. The 
ADRU manages the National Drug Treatment Reporting 
System (NDTRS). This system collects data on episodes of 
treatment, rather than on the individual person treated; 
neither does it provide outcome/exit data for all areas. In 
2005 the Health Research Board (HRB) developed a National 
Drug-Related Deaths Index (NDRDI), which subsequently 
published data for the period 1998–2005.2 The Health 
Protection Surveillance Centre (HPSC) introduced an 
extended surveillance system for hepatitis B in 2004 and for 
hepatitis C in 2007. The Steering Group notes that there 
has been no concerted effort to monitor the incidence and 
prevalence of hepatitis B, hepatitis C or HIV among drug 
users since the NDS 2001–2008 was launched. 
New drugs strategy published  (continued)
Inclusion of alcohol in new substance misuse strategy
Announcing the decision to develop a ‘substance misuse’ 
strategy, including both illicit drugs and alcohol, Minister of 
State with responsibility for drugs strategy, John Curran TD, 
said: ‘A combined strategy will facilitate a more coherent 
approach to the issues and consequences of alcohol and 
illicit drug use including addictive behaviours. We cannot 
continue to look at these problems in isolation.’9 A new 
steering group will be established in autumn 2009 to 
develop proposals for a strategy that will incorporate the 
already-agreed drugs policy element. Membership of the 
new steering group will refl ect the appropriate statutory, 
community/voluntary and other relevant interests. The 
group will be jointly chaired by offi cials from the Department 
of Health and Children and the Offi ce of the Minister for 
Drugs and will be asked to report by the end of 2010. 
The interim drugs strategy contains a number of proposals 
relating to alcohol. These are summarised below.
Supply reduction 
During the public consultation process, the issue of 
underage drinking was consistently raised, both as a 
problem in its own right and as a gateway to the use of illicit 
drugs. However, owing to the fundamental legal difference 
involved in their supply, the focus in the interim drugs 
strategy is on illicit drugs rather than on alcohol, with the 
exception of underage drinking. 
Prevention
Alcohol is referenced under this pillar with regard to 
developing a prevention strategy to tackle substance misuse, 
particularly in relation to under-18s. One of the key themes 
to emerge from the consultation process was the perception 
that drug and alcohol use are becoming more widespread 
and that the age profi le of those involved is getting younger. 
Measures to prevent and/or delay drug and alcohol use – 
especially among young people – are, therefore, particularly 
important and urgent.
The Steering Group is of the view that renewed efforts 
need to be made to address the issue of underage drinking, 
which is often perceived as the direct, or underlying, cause 
of many of the problems encountered by individuals and 
communities. The Group acknowledges the benefi ts of the 
enactment of the Intoxicating Liquor Act 2008. However, 
it also feels that the impact of the legislative measures, and 
the situation generally, should be monitored to ensure that 
alcohol is not being supplied to under-18-year-olds in an 
illegal or irresponsible way. 
Alcohol advertising and sponsorship (especially in the 
sporting context) are seen as particular problems, especially 
as the messages often target the young and impressionable. 
The Department of Health and Children established a 
working group to engage with relevant stakeholders and 
sporting bodies to examine the extent of sports sponsorship 
by alcohol companies and to consider how the health-
related concerns might be addressed. The working group 
is expected to report in autumn 2009. The Steering Group 
welcomes these developments.
Provision of recreational and other facilities for young people 
is considered to be important in preventing misuse of drugs 
and alcohol, and the Steering Group identifi es the lack of 
such facilities and appropriate supporting structures across 
the country as a key gap. The Group believes that access to 
school facilities outside school hours should be progressed as 
a matter of urgency.
The Steering Group is of the view that there is a need 
to further develop and promote prevention strategies 
in a number of other key areas – third-level institutions, 
workplaces, sports and other community and voluntary 
organisations – using brief interventions where appropriate.
The development of a tiered or graduated approach to 
prevention and education measures in relation to drugs and 
alcohol is recommended. This approach would provide a 
framework for the future design of targeted prevention and 
education interventions.
Treatment and rehabilitation 
The Steering Group endorses the view of the Working Group 
on Alcohol and Drug Synergies that greater coherence and 
co-ordination of alcohol and drug issues at policy, planning 
and operational levels are needed. With respect to treatment 
and rehabilitation, the Steering Group sees the re-orientation 
of all addiction services towards dealing with problem 
substance use as a key feature of the new strategy. 
The Steering Group acknowledges that it is not possible 
to quantify the number of problem alcohol users requiring 
treatment. However, the signifi cant difference between 
the number of alcohol-related hospital discharges and the 
number of reported cases receiving treatment for alcohol 
addiction indicates that there is a considerable cohort of 
problem alcohol users who could benefi t from engagement 
with addiction treatment services.
The Steering Group believes that training in brief 
interventions needs to be rolled out across the healthcare 
service to maximise the impact of this cost-effective 
approach. Early interventions, targeted at hazardous and 
harmful users of alcohol, are designed to reduce alcohol 
consumption before dependence develops. There is strong 
evidence to suggest that brief interventions provided within 
various healthcare settings, including primary care, general 
hospital wards, mental health services and emergency 
departments, are effective in reducing hazardous and 
harmful alcohol use. 
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Research and information
The Steering Group recommends the development of 
a research management framework in relation to problem 
substance use in Ireland. In relation to alcohol, it 
specifi cally recommends:
the development of appropriate epidemiological  ■
indicators of problem alcohol use, and building on 
existing monitoring systems and prevalence surveys;
measuring the impact of alcohol and drugs on the Irish  ■
health and justice systems; and 
monitoring problem substance use (including alcohol)  ■
among those presenting to hospital emergency 
departments. 
(Johnny Connolly, Brian Galvin, Martin Keane, Jean Long, Suzi 
Lyons, Deirdre Mongan and Brigid Pike) 
1. Department of Community, Rural and Gaeltacht Affairs 
(2009) National Drugs Strategy (interim) 2009–2016. 
Dublin: Stationery Offi ce.
2. Lyons S, Lynn E, Walsh S and Long J (2008) Trends in drug-
related deaths and deaths among drug users in Ireland, 1998–
2005. HRB Trends Series 4. Dublin: Health Research Board.
3. Organisation for Economic Co-operation and 
Development (2008) Ireland: towards an integrated public 
service. Paris: OECD. 
4. Whelan P, Arnold T, Aylward A, Doyle M, Lacey B, Loftus 
C, McLoughlin N, Molloy E, Payne J and Pine M (2003) 
Cross-departmental challenges: a whole-of-government 
approach for the twenty-fi rst century. Dublin: Institute of 
Public Administration.
5. Pike B (2008) Development of Ireland’s drug strategy 2000–
2007. HRB Overview Series 8. Dublin: Health Research 
Board.
6. The KPIs used to measure progress under the pillars in the 
NDS 2001–2008 were revised by the Steering Group that 
undertook the mid-term review of the drugs strategy.
7. Steering Group for the mid-term review of the National 
Drugs Strategy (2005) Mid-term review of the National 
Drugs Strategy 2001–2008. Dublin: Department of 
Community, Rural and Gaeltacht Affairs.
8. Working group on drugs rehabilitation (2007) National 
Drugs Strategy 2001–2008: rehabilitation. Dublin: 
Department of Community, Rural and Gaeltacht Affairs.
9. Curran J (2009) Alcohol and drugs to be joined in a 
National Substance Misuse Strategy. Press release issued 
31 March 2009 by the Department of Community, Rural 
and Gaeltacht Affairs.
New drugs strategy published  (continued)
Treated problem cocaine and opiate use, 
2002–2007 
In the summer of 2009 the Health Research Board published 
two papers in its Trends Series, one on problem cocaine use1 
and one on problem opiate use.2 The papers are based on 
data reported to the National Drug Treatment Reporting 
System (NDTRS). It is important to note that the NDTRS 
collects data on episodes of treatment, rather than the 
number of individual people treated each year. This means 
that individuals may appear more than once if they attend 
more than one treatment service in a year, and may reappear 
in subsequent years. 
The main fi ndings of the paper on treated problem cocaine 
use are:
One-fi fth (10,764) of all cases treated for problem drug  ■
use between 2002 and 2007, reported cocaine as a 
problem substance. The annual number of cocaine cases 
increased by 177%, from 954 in 2002 to 2,643 in 2007. 
This increase was in line with increases in cocaine seizures, 
cocaine use among the general population and cocaine-
related deaths during the same time period.
The number of cases who reported cocaine as their main  ■
problem drug increased by 502%, from 128 in 2002 to 
770 in 2007. The number of cases who reported cocaine 
as an additional problem drug increased by 128%, from 
826 in 2002 to 1,885 in 2007. 
The higher rates of new cases treated for cocaine as their  ■
main problem drug were in the north-eastern, south 
eastern and southern counties. The incidence of treated 
problem cocaine use was lower than expected in Dublin 
due to the fact than many problem cocaine users in 
Dublin also used opiates, and the opiate was categorised 
as their main problem drug while cocaine was categorised 
as an additional problem drug.
Almost four out of fi ve cases who reported cocaine as their  ■
main problem drug used more than one drug. Cocaine 
was used alongside opiates, cannabis, alcohol and ecstasy.
There appears to be two profi les of cocaine user entering  ■
treatment, those who use opiates alongside cocaine and 
those who use combinations of alcohol, cannabis and/or 
ecstasy alongside cocaine.
The majority of cases who reported cocaine as their  ■
main problem drug used it on two to six days per week, 
indicating that cocaine may be used as a week-end drug 
or during a binge.
Half of the cases were under 27 years old, 83% were  ■
men and 33% were employed. The proportion of treated 
cocaine cases in employment was higher than the 
proportion of opiate cases in employment, 35% versus 
13%, indicating that treated cocaine users were from a 
mix of social backgrounds.
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Cocaine and opiate use  (continued)
The majority (69%) of cases were treated in outpatient  ■
services in 2007. 
There is a wide variety of interventions provided to  ■
cocaine cases, though until there is national data on 
treatment outcomes it is diffi cult to comment on the 
effectiveness of these interventions. 
The main fi ndings of the paper on treated problem opiate 
use are:
In total, 11,392 cases were treated for problem  ■ opiate 
(mainly heroin) use in 2007, an increase of 29% on 
the fi gure of 8,804 in 2002. This increase in treatment 
provision is explained by a combination of factors, an 
increase in the number of treatment places, an increase 
in opiate use among the population and an increase in 
reporting to the NDTRS. 
This increase in treated problem opiate use was in line  ■
with increases in heroin seizures in 2005 and 2006, 
problem opiate use among the population and heroin-
related deaths during the same time period.
The rate of increase in new opiate cases was highest  ■
outside Dublin, and in particular in the midland, north 
eastern, and south eastern counties. 
The proportion of cases treated for opiates as a main  ■
problem drug who reported use of more than one drug 
decreased from 69% in 2002 to 63% in 2007. Between 
2002 and 2007, cannabis, benzodiazepines and, in more 
recent years, cocaine were the most common additional 
problem drugs used alongside opiates. The use of 
additional drugs alongside opiates makes it more diffi cult 
to treat the addiction successfully. 
Of the 3,575 cases who entered treatment and reported  ■
opiates as their main problem drug in 2007, 52% smoked 
it, 40% injected it, and 4% consumed it orally. 
Between 2003 and 2007 decreasing proportions of  ■
cases reported that injecting was their primary route 
of administration, while correspondingly increasing 
proportions reported smoking opiates. This is a good 
news story indicating that harm reduction messages are 
being implemented and the transmission of blood-borne 
viruses will be reduced among this cohort. 
The majority of cases who reported an opiate as their  ■
main problem drug used it daily, indicating the addictive 
nature of the drug. 
In 2007, the vast majority (75%) of opiate cases entering  ■
treatment were cared for in outpatient services. 
There is a wide variety of interventions provided to opiate  ■
cases, including counselling, methadone maintenance, 
brief intervention, and medically assisted opiate 
detoxifi cation. 
(Anne Marie Carew and Jean Long)
These Trends Series papers are available online at www.
hrb.ie/health-information-in-house-research/alcohol-drugs/
publications/
1. Bellerose D, Carew AM, Lyons S and Long J (2009) Trends 
in treated problem cocaine use in Ireland 2002–2007. HRB 
Trends Series 6. Dublin: Health Research Board. 
2. Carew AM, Bellerose D, Lyons S and Long J (2009) Trends 
in treated problem opiate use in Ireland 2002–2007. HRB 
Trends Series 7. Dublin: Health Research Board.
Treated problem alcohol use: ﬁ gures for 2007
Figures from the National Drug Treatment Reporting 
System (NDTRS) for treated problem alcohol use in Ireland 
for 2007 by HSE area of residence are currently available on 
the HRB website.1
Some of the main results are:
7,312 cases were treated for problem alcohol use in  ■
2007, an increase of 1,436 on the 5,876 cases treated 
in 2006. This may be attributed to an increase in the 
number of people presenting for treatment, or it may 
refl ect the increase in 2007 in the number of treatment 
centres participating in the NDTRS.
The prevalence of treated problem alcohol use among  ■
15–64-year-olds living in Ireland, expressed per 100,000 
of the population, increased from 182.9 in 2006 to 
222.6 in 2007.
The incidence of treated problem alcohol use among  ■
15–64-year-olds living in Ireland, expressed per 100,000 
of the population, increased from 109.8 in 2006 to 
118.3 in 2007.
These increases in prevalence and incidence may be  ■
explained by an increase in problematic alcohol use in 
the population, an increase in reporting to the NDTRS, 
or a combination of both.
One in fi ve of those treated for problem alcohol use in  ■
2007 also reported using at least one other substance, 
a similar proportion to that observed in 2006. The most 
commonly used additional drug was cannabis.
In 2007, the median age at which both new and  ■
previously treated cases began drinking was 16 years, 
the same as in the previous three years.
The median age of all treated cases was 39 years; for  ■
new cases, the median age continued to be slightly 
younger (37 years). While the overall proportion of 
cases under the age of 18 remained small, the numbers 
of previously treated and new cases in that age group 
continued to rise. 
The majority of those treated for problem alcohol use  ■
were male, with low levels of employment. 
Signifi cant improvements in the NDTRS data collection 
processes and procedures mean that the HRB is now able to 
report on the information collected from alcohol treatment 
services on a more regular basis.
(Suzi Lyons)
1. Alcohol and Drug Research Unit (2009) Treated problem 
alcohol use in Ireland: fi gures for 2007 from the National 
Drug Treatment Reporting System. Dublin: Health 
Research Board. Available at www.hrb.ie/publications/
alcohol-drugs
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New information on polydrug use in 
Ireland
The fi fth bulletin of results from the 2006/7 all-Ireland 
general population drug prevalence survey1 (a follow-on 
from the fi rst such survey in 2002/32) focuses on polydrug 
use in the adult population (15–64 years) and patterns 
of polydrug use. The fi nal achieved sample was 4,967 in 
Ireland. This represents a response rate of 65%. 
For the purpose of Bulletin 5, polydrug use is defi ned as 
the use in the last month of two or more of the following 
substances: alcohol, tobacco, any illegal drug or any other 
legal drug (sedatives, tranquillisers or anti-depressants). 
Just under one-fi fth (19.6%) of the 4,967 survey respondents 
reported that they had not used any substance in the last 
month. Among those who had used drugs in the last month, 
the most common substance combinations were:
26.5% had used alcohol and tobacco 1. 
3.3% had used alcohol, sedatives or tranquillisers, 2. 
and anti-depressants 
2.6% had used alcohol and at least one illegal drug 3. 
2.4% had used tobacco and at least one illegal drug 4. 
2.3% had used tobacco, sedatives or 5. 
tranquillisers, and anti-depressants 
2.2% had used alcohol, tobacco and 6. 
at least one illegal drug 
1.9% alcohol and sedatives or tranquillisers 7. 
1.9% alcohol and anti-depressants8. 
1.6% had used alcohol, tobacco, sedatives or 9. 
tranquillisers, and anti-depressants 
1.5% had used tobacco and anti-depressants 10. 
The combination of alcohol, tobacco and any illegal drug 
was more commonly reported by men (3.4%) than by 
women (0.9%). Thirty-one per cent of young adults (15–34 
years) reported that they had used alcohol and tobacco, 
compared to 23% of older adults (35–64 years). The same 
relationship was observed among users of alcohol, tobacco 
and at least one illegal drug, with 3.8% of young adults and 
0.8% of older adults reporting this combination. 
The results of the polydrug use survey refl ect substance use 
in recreational situations, rather than problematic substance 
use in socially deprived areas or among treated problem 
drug users.
(Jean Long)
1. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit (2009) Drug 
use in Ireland and Northern Ireland. 2006/2007 drug 
prevalence survey: polydrug use results. Bulletin 5. 
Dublin: NACD.
2. National Advisory Committee on Drugs and Drug and 
Alcohol Information and Research Unit (2007) Drug 
use in Ireland and Northern Ireland. 2002/2003 drug 
prevalence survey: polydrug use results. Bulletin 5. 
Dublin: NACD.
Treated problem drug use: ﬁ gures for 
2007
Figures from the National Drug Treatment Reporting 
System (NDTRS) for treated problem drug use in Ireland for 
2007 by HSE area of residence are currently available on the 
HRB website.1 
Some of the main results are:
13,620 cases were treated in 2007, of whom 5,977 entered 
treatment in that year. The majority of cases attended 
outpatient services. 
The prevalence of treated problem drug use among 
15–64-year-olds living in Ireland per 100,000 of the 
population increased by 4%, from 426 in 2006 to 445 
in 2007.
New cases entering treatment are an indirect indicator of 
recent trends in problem drug use. The incidence of treated 
problem drug use among 15–64-year-olds living in Ireland 
per 100,000 of the population increased from 75 in 2006 to 
80 in 2007. 
An opiate (mainly heroin) was the most common main 
problem drug reported by cases entering treatment in 2007.
The majority (67.1%) of cases treated in 2007 reported 
problem use of more than one substance, which was slightly 
lower than the 2006 fi gure (71.1%). Alcohol was reported as 
an additional problem substance in 40% of all treated cases.
Many problem drug users in treatment are young and 
male, have low levels of education and are unlikely to be 
employed. 
Almost 14% of all new cases treated in 2007 were aged 
under 18 years, a slight increase on the 2006 fi gure. Almost 
3% of previously treated cases were aged under 18 years, as 
in 2006. 
Signifi cant improvements in the NDTRS data collection 
processes and procedures mean that the HRB is now able to 
report on the information collected from treatment centres 
on a more regular basis.
(Suzi Lyons)
1. Alcohol and Drug Research Unit (2009) Treated problem 
drug use in Ireland: fi gures for 2007 from the National 
Drug Treatment Reporting System. Dublin: Health 
Research Board. Available at www.hrb.ie/publications/
alcohol-drugs
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Comptroller and Auditor General report 
on drug treatment
The Comptroller and Auditor General published a report 
entitled Drug treatment and rehabilitation on 6 June 2009.1 
The drug treatment services examined in this report were 
those caring for people with addiction to illegal drugs 
(mainly cannabis, cocaine, ecstasy and heroin). The 
report reviewed:
the extent to which the demand for drug treatment and  ■
rehabilitation services is being met;
the timeliness of access to drug treatment; ■
the extent to which the effectiveness of drug treatment  ■
and rehabilitation services are evaluated; and
the effectiveness of the arrangements for co-ordination  ■
of drug treatment and rehabilitation at an individual case 
level, and nationally.
This article presents the fi ndings with respect to drug 
treatment. 
Treatment for problem opiate use
It has been estimated that there were between 12,884 and 
15,883 problem opiate (mainly heroin) users in Ireland 
in 2001. Up to 2000, opiate use was concentrated in the 
greater Dublin area, but at the time of this report there 
was evidence that it had spread throughout the country. 
Methadone substitution treatment is the main form of 
treatment for opiate addiction in Ireland. At the end of 
2007, just over 8,000 people were receiving methadone 
treatment. Around one-third of those receiving methadone 
treatment are cared for by private general practitioners. 
Needle-exchange services are provided in some areas, with 
the aim of reducing the risks associated with the sharing of 
injecting equipment. According to this report, there was 
some increase in the provision of needle-exchange services 
between 2001 and 2009, but gaps in service provision 
remain. The authors report that in the period under review 
the numbers of opiate users who received detoxifi cation 
treatment and the numbers who attended follow-on 
rehabilitation treatment were very low when compared 
with the numbers who received methadone treatment. 
They estimate that the extent of detoxifi cation treatment 
provision was in the region of 100 courses of treatment 
per year. While the authors acknowledge that long-term 
methadone maintenance is likely to be the best outcome 
that can be achieved for a signifi cant proportion of opiate 
users, they suggest that the HSE set targets for rates of 
progression through the various forms of treatment. 
Treatment for problem drug use (excluding opiates) 
The prevalence of cannabis and cocaine use among the 
general population increased between 2002/3 and 2006/7. 
The authors assume that the habitual use of a number of 
other drugs was also on the increase between the two 
survey time periods. The authors report that, despite 
this, there did not appear to have been a commensurate 
increase in the number of cases treated for problem use of 
cannabis over the life of the National Drugs Strategy. The 
fi ndings of the review indicate that changes in the pattern 
of drug misuse (e.g. heroin addiction outside of Dublin and 
cocaine addiction in Dublin) created a challenge that service 
providers and planners found diffi cult to address. The review 
notes that many clients report multiple addictions. The 
current pattern of drug use suggests that there are, in effect, 
two separate client groups for whom drug treatment needs 
to be provided:
those with a largely opiate-based addiction problem,  ■
with more than three in fi ve reporting multiple drug use, 
concentrated in certain marginalised and poor sectors 
of society; 
those with problem use of drugs such as cannabis,  ■
cocaine and ecstasy, spread more widely across social 
groups and geographic areas.
Although the prevalence of illegal drugs such as cannabis 
and cocaine was higher in Dublin than in the rest of the 
country, the rate at which users of these drugs entered 
treatment appeared to be signifi cantly lower in Dublin than 
elsewhere. The authors note that there is a risk that the 
uptake of addiction treatment refl ects the available services 
in a geographical area rather than the needs of the people 
living in the area. 
Demand for treatment
Accurate information about the level of demand for 
treatment for problem drug use is very important for service 
planning purposes. A database on treated drug and alcohol 
use in Ireland is compiled and managed by the Health 
Research Board (HRB). This database, the National Drug 
Treatment Reporting System (NDTRS), relies on treatment 
service providers to collect details on each individual who 
presents for treatment. The information is transmitted to 
the HRB, without personal identifi cation details (e.g. name 
or address) of the individuals receiving treatment. The result 
is that while the number of courses of treatment delivered 
can be identifi ed, it is not possible to track the progression 
of an individual from one service provider to another. The 
review notes that ‘the NDTRS has the potential to generate 
better estimates of demand for treatment, but greater 
compliance by service providers with the NDTRS data input 
rules would be required if this is to be achieved.’ The review 
recommends that ways of recording treatments sought 
and provided on an individual basis and in a manner that 
ensures security of the information. The authors go on 
to recommend that this should be tackled by the HRB in 
liaison with service providers and with the Data Protection 
Commissioner. 
Access to treatment
This review reported that the NDTRS data may 
underestimate the extent of waiting for assessment. The 
practice in some areas is that recording of information for 
NDTRS purposes starts only at the time of assessment, 
rather than at the time of initial presentation or referral. 
Some service providers also operate ‘informal’ waiting 
lists, and call those on the informal list only when an 
assessment appointment becomes available. In addition, 
where drug users are aware of long waiting times for access 
to local services, they may be deterred from presenting 
for assessment. The HRB provides a protocol defi ning the 
terms referral, assessment and treatment, but needs to put 
more emphasis on ensuring that all service providers record 
information completely and accurately so that the true 
extent of waiting for treatment may be gauged. Subject to 
these limitations, analysis of NDTRS data indicates that an 
estimated 82% of those beginning methadone treatment 
in 2007 commenced treatment within the one-month 
target following assessment. In almost all cases treated 
for cannabis, cocaine or other stimulants, treatment was 
provided within the one- month target. 
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C & AG report on drug treatment  (continued)
Alcohol use among opiate users in 
methadone treatment
Ryder and colleagues estimated that 35% (95% CI = 
28%–41%) of a sample of current or former heroin users 
attending general practice for methadone treatment were 
problem alcohol users, and that 14% of the sample were 
dependent users.1 According to data from the National Drug 
Treatment Reporting System, 24% of opiate users entering 
opiate treatment reported alcohol as an additional problem 
drug, which is lower than the estimate presented here.
The authors surveyed 196 patients, which represented 8% of 
those on the Central Treatment List,2 31% of those sampled 
and 71% of those invited by their general practitioner to 
participate. The response rate was lower than desired – an 
indication of the diffi culty than can be associated with 
doing research among patients attending private general 
practitioners in Ireland. 
The survey questionnaire included the Alcohol Use Disorders 
Identifi cation Test (AUDIT) to assess participants’ alcohol use. 
The questionnaire also collected data on socio-demographic, 
medical and substance use characteristics. The median 
age of the 196 participants was 32 years, 68% were male, 
79% said that they had used one or more illicit drugs in the 
previous month, and 76% had ever injected drugs. Of those 
who knew their blood-borne viral status, 55% said that they 
were hepatitis C positive and 5% said that they were HIV 
positive. Other research indicates that self-reported hepatitis 
C and HIV status can both over- and under-estimate the 
prevalence of these infections and should be interpreted 
with caution. 
The cases classifi ed as problem alcohol users were 
signifi cantly more likely to have attended a local emergency 
department in the previous year and less likely to have 
attended a hospital clinic in the previous year compared 
to those who were not problem alcohol users. Among the 
107 respondents who reported that they were hepatitis 
C positive, those who were problem alcohol users were 
signifi cantly less likely to have attended a specialist 
hepatology clinic than their counterparts. 
The authors concluded that problem alcohol use has a 
high prevalence among current or former heroin users 
attending primary care for methadone treatment, and that 
interventions that address this issue should be explored as 
a priority.
(Jean Long)
1. Ryder N, Cullen W, Barry J, Bury G, Keenan E and 
Smyth BP (2009) Prevalence of problem alcohol use 
among patients attending primary care for methadone 
treatment. BMC Family Practice, 10(42). Accessed on 14 
July 2009 at www.biomedcentral.com/1471-2296/10/42 
2. The Central Treatment List is a complete register of 
all patients in Ireland being prescribed methadone by a 
registered medical practitioner for the treatment of 
opiate misuse.
While a high proportion of individuals commenced 
treatment within the one-month target, approximately 460 
people were recorded as waiting for methadone treatment 
in April 2008. The average waiting time for those on the lists 
in some areas was over a year. 
A target of carrying out an assessment within three days of 
presentation (or referral) for treatment has been set. Of the 
opiate cases recorded by the NDTRS for 2007, an estimated 
61% were reported to have been assessed within three 
days of initial presentation. Almost one in eight of those 
assessed were reported to have waited more than a month 
for their assessment. For persons presenting for assessment 
for problem cocaine use in 2007, 56% were recorded as 
having been assessed within the three-day target. Of those 
presenting for assessment for cannabis or stimulant use 
problems, less than 40% were assessed within the target 
time.
Effectiveness of treatment
Evaluation of treatment effectiveness is complex. 
Nonetheless, some sound and informative work has been 
done in relation to treatment of opiate addiction in Ireland. 
The ROSIE study2 found that there had been reductions 
among those interviewed in the reported rates of illicit 
use of drugs and of involvement in crime after one year 
in treatment, and increased rates of employment and 
independent living after three years in treatment. No 
signifi cant improvement in health status was noted. 
The effectiveness of treatment for problem use of drugs 
other than opiates needs to be evaluated.
(Jean Long)
1. Comptroller and Auditor General (2009) Drug addiction 
treatment and rehabilitation. Special report, Value for 
Money 64. Accessed June 2009 at http://audgen.gov.ie/
viewdoc.asp?DocID=1142
2. The Research Outcome Study in Ireland (ROSIE) is a 
large-scale longitudinal study of outcomes achieved for a 
sample of over 400 people receiving treatment for opiate 
addiction or availing of needle exchange in 2003/2004. 
See www.nacd.ie/publications/ROSIE3-YearReport.pdf
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Morbidity among opiate users in 
methadone treatment
Cullen and colleagues completed a study of problem opiate 
users attending general practice for methadone treatment 
to estimate the prevalence of chronic illness and examine 
patterns of health service utilisation among this group 
compared with matched controls.1 The cases and controls 
were matched for practice, age, gender and general medical 
service (GMS) status. Data were collected on a sample of 114 
patients attending three general practices: 57 cases attending 
for methadone treatment (19 per practice) and 57 controls 
attending for primary care (19 per practice). 
Illness among methadone cases
The average age of cases was 37.2 years, 42 (74%) were male, 
41 (72%) had GMS cover, all were Irish nationals and 56 
(98%) lived in stable accommodation. Considerable lifetime 
contact with the practice was observed: 16 patients (28%) 
had been attending the practice for less than fi ve years, 21 
(37%) for between fi ve and 10 years, and 20 (35%) for more 
than 10 years. There were three reasons for initial contact 
with the general practice: registration for general medical 
care (20 patients), treatment of illicit drug use (20 patients), 
and referral by specialist addiction treatment services for 
methadone treatment (17 patients). All patients had been 
prescribed methadone by specialist addiction services prior 
to attending the general practice for methadone treatment, 
and 14 (25%) had been referred back to specialist addiction 
services since commencing methadone treatment at the 
practice (six in the previous year). The average dose of 
methadone prescribed (based on the last issued prescription) 
was 66 mg daily. 
Figure 1 presents a comparison of the morbidity profi le 
and health service utilisation characteristics of patients on 
methadone compared to their matched controls. Fifty-two 
patients (91%) had one or more chronic illnesses (in addition 
to opiate dependence) documented in their clinical record. 
Hepatitis C (38, 66%), depression (20, 35%), asthma (14, 
25%), HIV/AIDS (8, 14%) and DVT/varicose veins/thrombo-
phlebitis (4, 7%) were the most common chronic illnesses 
recorded. Thirty-nine patients (68%) were on regular 
prescribed medication in addition to methadone. Thirty-one 
patients (54%) had had at least one acute condition during 
the previous three months, of which the most common were: 
upper respiratory tract infection (10, 18%), insomnia, anxiety 
or depression (4, 7%), abdominal pain (4, 7%), urinary tract 
infection (3, 5%) and ear wax (3, 5%). Tobacco use was noted 
in the records of 39 patients, of whom 37 were recorded as 
smokers. Twenty-fi ve patients (44%) had been prescribed at 
least one time-limited medication (in addition to methadone) 
for the treatment of an acute illness during the previous three 
months. In the previous six months, patients had attended 
their GP for issues other than their addiction care an average 
of four times, and 27 patients (47%) had either been referred 
to or attended secondary care.
Figure 1 Comparison of morbidity profi le and health service utilisation by patients on methadone and matched 
controls attending inner city general practices in Dublin
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Alcohol affordability linked to harmful use
The European Commission (EC) commissioned RAND Europe 
to conduct a study on the affordability of alcohol products 
across the European Union (EU), and the potential impacts 
of affordability on harmful use of alcohol. The study’s 
fi ndings are presented in a report published in April 2009.1 
Alcohol is an important economic commodity in Europe, 
creating jobs, generating revenue in the form of alcohol 
taxes, and contributing around €9 billion to the EU 
economy through trade. However, alcohol is the third 
leading risk factor for death and disability in the EU, after 
tobacco and hypertension, and in 2003 it was estimated that 
the costs of alcohol misuse in the EU exceeded €125 billion. 
The aims of this study were:
to examine the link between the affordability of alcohol,  ■
alcohol consumption and alcohol-related harms;
to study the impact of cross-border tax-driven or  ■
competition-driven price differentials, which are an 
important policy concern for the EU; and
to examine the policy levers that can infl uence the  ■
affordability of alcohol.
In the past decade alcohol has become more affordable in 
all EU countries examined, apart from Italy. In six countries, 
including Ireland, affordability of alcohol increased by 50% 
or more. The analysis in this report indicates that, across 
the EU, 84% of the increase in alcohol affordability was 
driven by increases in income, and only 16% was driven 
by changes in alcohol prices. While incomes went up 
considerably across the EU, the relative price of alcohol has 
remained relatively stable, or has fallen at a slower rate than 
the income increases, in most of the EU countries included in 
this analysis.
Rates of excise duty on alcohol are not harmonised, and 
large variations in taxation exist across the EU despite the 
single European market and the introduction of minimum 
excise duty rates in 1992. Ireland, along with Sweden and 
Finland, has set higher rates on alcohol than other countries. 
However, except in the UK and Italy, the real value of alcohol 
taxation has decreased in the last decade across the EU. 
There is a trend across the EU towards more off-trade alcohol 
consumption, which tends to be cheaper than alcohol sold 
on-trade. In the UK, Sweden, Finland, Latvia, Ireland and the 
Netherlands, off-trade alcohol sales appear to be growing 
relative to on-trade sales. This is true even in countries in 
which the market share of the on-trade has traditionally 
been larger, such as Ireland and the Netherlands. In Ireland, 
for example, the off-trade share of the alcohol market in 
monetary terms grew from 19.1% in 1991 to 27.5% in 
2000 and to 35.6% in 2006 (although, according to other 
estimates provided in the survey, the increase in the share of 
off-trade alcohol sales has been larger, from around 30% to 
50% in the last fi ve years). It is possible that one of the main 
reasons for the increase in off-trade alcohol consumption is 
lower prices. In Ireland, alcohol prices in the off-trade appear 
to be decreasing relative to on-trade prices.
Existing evidence indicates that there is a negative 
relationship between alcohol price and consumption, and a 
positive relationship between income and consumption. In 
accordance with these fi ndings, the analysis presented in this 
report indicates that there is a statistically signifi cant positive 
relationship between alcohol affordability (a composite 
measure looking at the effect of price and income) and 
consumption across the EU. More specifi cally, a 1% increase 
in affordability results in an increase of 0.32% in total 
consumption. These elasticities are symmetrical, that is, a 
1% increase in affordability has the same degree of effect as 
a 1% decrease in affordability.
The report also noted positive, statistically signifi cant 
associations between alcohol consumption and related 
harm. More specifi cally, it reported that a 1% increase in per 
capita alcohol consumption was associated with increases of 
0.85% in fatal traffi c accidents, of 0.61% in traffi c injuries, 
and of 0.37% in the incidence of liver cirrhosis within the 
same year. 
This and many other studies indicate that the price and 
affordability of alcohol impact on levels of harmful and 
hazardous alcohol consumption; policy-makers should 
therefore consider introducing alcohol-pricing policies as 
effective measures to curb hazardous and harmful drinking 
in Europe. As the problem is multi-factorial, policies aimed 
at infl uencing the price/affordability of alcohol should not 
be the only elements of a country’s alcohol strategy. Other 
policies with a strong evidence base are also effective in 
reducing hazardous and harmful alcohol consumption, such 
as reducing alcohol outlet density, increasing minimum legal 
drinking ages, and enforcing drink-driving counter-measures. 
(Deirdre Mongan)
1. Rabinovich L, Brutscher P, de Vries H, Tiessen J, Clift 
J and Reding A (2009) The affordability of alcoholic 
beverages in the European Union: understanding the link 
between alcohol affordability, consumption and harms. 
Cambridge, UK: RAND Europe. Available at www.rand.
org/randeurope/publications.
Comparison with matched control group
The average age of controls was 37.2 years, 42 (74%) were 
male, 41 (72%) had GMS cover, all were Irish nationals and 38 
(67%) lived in stable accommodation. Morbidity and health 
service utilisation rates were high among this group also 
(Figure 1). Patients attending for methadone treatment were 
signifi cantly more likely to have a chronic illness, 
to be prescribed recurrent medication and to attend a 
general practice. 
(Jean Long)
1. Cullen W, O’Brien S, O’Carroll A, O’Kelly FD and Bury G 
(2009) Chronic illness and multimorbidity among problem 
drug users: a comparative cross sectional pilot study in 
primary care. BMC Family Practice, 10(25). Accessed 14 July 
2009 at www.biomedcentral.com/1471-2296/10/25 
Morbidity among opiate users  (continued)
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Young people’s exposure to alcohol 
marketing
The National Youth Council of Ireland (NYCI) launched 
the report Get ‘em young; mapping young people’s exposure 
to alcohol marketing in Ireland1 on 9 June 2009. The aim 
of this project was to map (document, describe and 
provide examples) young people’s exposure to alcohol 
marketing practices and to examine whether Ireland’s stated 
commitment to protecting young people from the 
pressure to drink is refl ected in the actual experience of 
young people. 
In 2003, the alcohol industry set up a company (Central 
Copy Clearance Ireland Ltd) to vet and approve all alcohol 
advertisements to ensure the content was in line with the 
voluntary code of the Advertising Standards Authority of 
Ireland (ASAI) and the Broadcasting Commission of Ireland 
(BCI) code. In 2004, the alcohol and advertising industries 
introduced a voluntary code of practice regarding alcohol 
advertising which was endorsed by the Minister for Health 
and Children. Under this code, no alcohol advertisements 
would be shown during TV and radio programmes where 
more than 33% of the audience was under 18 years of age. 
When applied to outdoor advertising, 33% of all available 
space could be used for alcohol advertisements, in other 
words, no ‘wrap rounds’ are permitted. A revised voluntary 
code has been in place since mid-2008. The two main 
changes to the code are that the audience profi le cut-
off is now 25% instead of 33% and, where advertising is 
permitted, alcohol advertisements will be limited to 25% of 
the available space. While some changes have been made to 
the volume of alcohol marketing (supply side), no evaluation 
has taken place to assess whether these changes have 
provided any real protection for children, or what impact 
they have had on young people’s decision to drink and how 
they drink (demand side).
Sixteen young people were selected from each province 
through the NYCI network and invited to participate in 
this research. There were more males than females in the 
group and the majority were aged 16–17 years. Three were 
aged 18–19 years to ensure that a full range of venues such 
as pubs/nightclubs could be included in the study. Data 
were collected in 2007 by a team of trained young people, 
supervised and supported by a youth leader and an alcohol 
researcher. Participants were asked to collect examples of 
alcohol marketing practices. Full details of the marketing 
practices observed (place, beverage type, brand name, 
marketing practice and its appeal) were recorded and, where 
possible, examples provided.
The main fi ndings of the research project were:
Sixteen communication channels that exposed young  ■
people to alcohol marketing practices were documented 
– the most commonly mentioned being television, 
magazines/newspapers, internet, street fl yers, billboards 
and supermarkets/shops.
Packaging of spirits and alcopops was considered  ■
the most attractive, with the shape and colour of the 
bottles and the colour of the product itself the main 
attractive features.
Integrated marketing was common; two-thirds of the  ■
young people reported that they had seen the same 
alcohol products in a number of media channels.
One in every four of the alcohol marketing practices  ■
recorded involved a price promotion, such as special 
offers, free alcohol, volume sales and deep discounts, 
with street fl yers and supermarkets the main channels of 
communication.
Of all the marketing practices recorded, six out of every  ■
10 appealed to young people, with spirits, alcopops 
and three beer brands (Carlsberg®, Guinness® and 
Heineken®) having the most appeal. 
Marketing practices that appealed to young people  ■
occurred in all communication channels. Within the 
broadcast media, almost two-thirds of the marketing 
practices were appealing. In the case of outdoor media, 
six out of 10 marketing practices were considered 
appealing by young people.
The elements of the alcohol marketing practices that  ■
particularly appealed to young people were humour, 
cleverness, cheap/free alcohol and attractiveness.
Eight of the top 10 most appealing alcohol marketing  ■
practices agreed by the youth researchers were television 
advertisements. In addition a product placement (alcohol 
portrayal in fi lm) and price promotion (8 beers for €8) 
made the top ten list. 
Alcohol marketing has an impact on youth drinking and 
it is clear that young people in Ireland are exposed to 
marketing practices which can be described as pervasive 
through a variety of channels and on a regular basis. One in 
every four of the alcohol marketing practices documented 
involved price promotions which young people considered 
very attractive. Cheap alcohol, in the form of alcohol price 
promotions, has been shown to increase binge drinking in 
young people.
Despite the pre-vetting system for all alcohol advertisements, 
established by the drinking industry in Ireland in 2003, 
young people continue to fi nd alcohol advertisements 
appealing, with humour, cleverness, cheap offers of alcohol 
and attractiveness the most effective elements. In addition, 
the introduction of audience profi ling for the placement 
of alcohol advertisements by the drinks industry does not 
appear to have protected young people, given the range 
of alcohol advertising and promotion practices that young 
people documented. 
The report concludes that there are over one million young 
people under 18 years of age in Ireland. These young people 
need adequate protection from an unnecessary exposure to 
risk – marketing practices that promote alcohol, a substance 
that carries serious health and social risks for young people.
(Deirdre Mongan)
1. National Youth Council of Ireland (2009) Get ‘em young: 
mapping young people’s exposure to alcohol marketing in 
Ireland. Dublin: NYCI.
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Drug tests in Irish prisons
Information on drug testing in prisons in 2008 was obtained 
from the Irish Prison Service. These data indicate that more 
than 20,000 voluntary tests were carried out to monitor 
drug use and responses to treatment. These tests included 
those carried out on committals (new entries) as well as 
those carried out on existing inmates. It may be assumed 
therefore that some of the positive test results relate to drugs 
or alcohol consumed outside the prison. 
Between one-third and one-half of those screened tested 
positive for at least one drug. The common metabolites 
detected indicated use of cannabis, benzodiazepines and 
opiates (Table 1). It is not clear whether the numbers of 
positive cases exclude prisoners who were prescribed 
benzodiazepines; if they do not, these fi gures overstate the 
extent of unregulated use of benzodiazepine in prisons. 
Cocaine and alcohol were detected in a small number of 
tests. The profi le of positive opiate and benzodiazepine tests 
indicated moderate use of such drugs among prisoners 
tested in Mountjoy, Wheatfi eld, Limerick, Midland and 
Cloverhill prisons. The proportion of positive tests was low 
in St Patrick’s Institution and in Castlerea and Cork prisons. 
It would be useful if the test results of prisoners who were 
tested at committal interview could be removed from this 
analysis as this would provide a more accurate assessment of 
drug use in Irish prisons.
(Jean Long)
Table 1 Number of tests, by prison, and number (%) of positive tests, by prison and by drug type, 2008
Prison
No. 
of tests
Cannabis
Benzo
diazepines Methadone Opiates Cocaine Alcohol
Amph-
etamines
Number (%)
Mountjoy Male 3279 1491 (45) 1619 (49) 3075 (94) 1714 (52) 46 (1) 12 (0.4) 22 (0.7)
Dochas Centre 2933 772 (26) 1692 (58) 2433 (83) 816 (28) 179 (6) 58 (2) 8 (0.3)
Training Unit 2849 31 (1) 17 (0.6) 0 (0) 23 (1) 2 (0.1) 14 (0.5) 8 (0.3) 
Wheatfi eld 2552 1026 (40) 782 (31) 1886 (74) 913 (36) 18 (0.7) 15 (0.6) 3 (0.1)
Cloverhill 3191 853 (27) 1265 (40) 2292 (72) 1179 (37) 333 (10) 87 (3) 24 (0.8)
St Patrick’s Inst. 2457 133 (5) 71 (3) 300 (12) 27 (1) 0 (0.0) 12 (0.5) 1 (0.04)
Castlerea 164 43 (26) 55 (34) 11 (7) 21 (13) 6 (4) 3 (2) 3 (2)
Loughan House 567 157 (28) 105 (19) 2 (0.4) 21 (4) 2 (0.4) 8 (1) 2 (0.4)
Shelton Abbey 887 214 (24) 118 (13) 7 (0.8) 38 (4) 5 (0.6) 23 (3) 9 (1)
Limerick 496 155 (31) 211 (43) 425 (86) 187 (38) 2 (0.4) 2 (0.4) 1 (0.2)
Cork 153 2 (1) 20 (13) 0 (0.0) 5 (3) 0 (0.0) 0 (0.0) 0 (0.0)
Midland 3452 785 (23) 892 (26) 3063 (89) 1423 (41) 58 (2) 14 (0.4) 11 (0.3)
Portlaoise 18 4 (22) 10 (56) 4 (22) 3 (17) 1 (6) 0 (0.0) 1 (6)
Arbour Hill 46 6 (13) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Source: Data provided by the Irish Prison Service
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Fall in number of HIV cases associated 
with drug use
Voluntary linked testing for antibodies to HIV has been 
available in Ireland since 1985. According to the most recent 
report of the Health Protection Surveillance Centre (HPSC),1 
at the end of 2008 there were 5,186 diagnosed HIV cases 
in Ireland, of whom 1,417 (27%) were probably infected 
through injecting drug use. 
Figure 1 presents the number of new cases of HIV among 
injecting drug users reported in Ireland, by year of diagnosis; 
data from 1982 to 1985 were excluded from the fi gure as 
these four years were combined in the source records. Figure 
1 is based on data reported to the Department of Health 
and Children, the National Disease Surveillance Centre and 
its successor, the HPSC. There was a fall in the number of 
HIV cases among injecting drug users between 1994 and 
1998, with about 20 cases per year, compared to about 
50 cases each year in the preceding six years. There was 
a sharp increase in the number of cases in 1999 (69 new 
cases), which continued into 2000 (83 new cases). Between 
2001 and 2008 there was an overall decline in the number 
of new injector cases (38, 50, 49, 71, 66, 57, 54 and 36 
respectively) when compared to 2000. It was diffi cult to 
interpret the trend owing to the relatively small numbers 
diagnosed each year, so a smoother curve (red plot line in 
Figure 1) was calculated using a rolling centred three-year 
average. This curve presents a new baseline of between 45 
and 65 cases each year. 
Of the 36 new HIV cases among injecting drug users 
reported to the HPSC in 2008, 27 were male and nine were 
female, and the average age was 33 years. Twenty-two of 
the 34 cases with a known address lived in the HSE Eastern 
Region (Dublin, Kildare and Wicklow). 
(Jean Long)
1.  O’Donnell K, Moran J and O’Hora A (2009) HIV 
& AIDS in Ireland 2008. Dublin: Health Protection 
Surveillance Centre. Available at www.hpsc.ie/
hpsc/A-Z/HepatitisHIVAIDSandSTIs/HIVandAIDS/
SurveillanceReports/
Figure 1 Actual number and rolling average number of new cases of HIV among injecting drug users reported in 
Ireland, by year of diagnosis, 1986 to 2008
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Information leaﬂ et on needle-
exchange services
In July 2009, the HSE East Coast Area needle-
exchange service launched an information leafl et 
for people who inject drugs. The aim of the leafl et 
is to encourage injectors not to share and never to 
re-use injecting equipment. 
The leafl et includes advice about safer injecting 
practices and provides guidance on how to look 
after veins and limit vein damage. It stresses 
the importance of never sharing drug-taking 
equipment to help prevent the transmission or 
acquisition of hepatitis and HIV. While the main 
focus is on injecting drug use, the leafl et states 
that blood-borne viruses can also be transmitted or 
acquired by sharing snorting equipment. 
Service users are encouraged to seek further advice 
from needle-exchange services, which are listed in 
the leafl et, with their opening hours and contact 
details. Services providing HIV/AIDS prevention 
strategies in the Dublin 4 area are advertised. 
Drug treatment and counselling services in the 
Dublin South East, East Wicklow and Dun Laoghaire 
areas also are identifi ed. For people seeking 
treatment and counselling services in other areas, a 
helpline number is given. The community addiction 
teams in the greater Dublin and East Wickow areas 
are listed with their contact details.
John Craven, senior outreach worker in the HSE East 
Coast Area, designed the information leafl et. It was 
funded by the Dun Laoghaire Rathdown Local Drugs 
Task Force, and will be distributed to all Irish needle-
exchange services. There are plans to evaluate the 
impact of the leafl et among service users.
(Janet Robinson)
For further information, contact John Craven at 
(01) 280 3335 or 086 859 0734
Drug-using sex workers exposed 
to multiple risks and harms
A large-scale qualitative study has highlighted the 
need for adequately resourced support structures 
to reduce the risk of harm to drug-using sex 
workers in Ireland. The fi rst of its kind, this study 
by the National Advisory Committee on Drugs 
(NACD) explored the local risk environment within 
which drug-using sex workers in Dublin live and 
work.1 The authors conclude that wider social and 
situational factors, such as poverty, housing, health, 
educational needs and employment prospects, 
are as fundamental to reducing risk of harm in this 
vulnerable group as addressing drug use.
In-depth interviews were conducted with 35 
drug users currently or formerly engaged in sex 
work, and biographical, drug use and offending 
behaviour data were collected by means of a brief 
questionnaire. In addition, interviews were held 
with 40 professionals across community, voluntary 
and statutory sectors whose work either directly or 
indirectly impacted on drug-using sex workers. This 
intensive, qualitative approach revealed that there is 
a range of behaviours associated with drug use and 
its accompanying lifestyle which place an individual 
at particular risk of harm. 
For the most part, participants in the study 
grew up in communities associated with social 
and economic marginalisation and high levels 
of unemployment. They moved more or less 
continually through drug and alcohol services, 
homeless hostels, the judicial system and other 
social care agencies. Participants used a range of 
strategies to reduce danger, yet their perception 
of risk was relative to their situation, thus leading 
them to treat some risks as acceptable or necessary. 
Current harm reduction interventions tend to focus 
on individual risk behaviour, often overlooking the 
wider social contexts in which members of this 
group live and work.
Arising from analysis of the research, 
the NACD recommends:
continued and adequate funding of existing  ■
services that deal with this client group; 
expansion of outreach services (particularly  ■
out of hours) to target existing and developing 
street sex markets, and development of peer 
outreach to areas of the city with known 
networks of drug-using sex workers;
The Irish Needle Exchange Forum website was launched earlier this year as the fi rst dedicated online 
resource for needle exchange services in Ireland. The site aims to provide those working in needle 
exchanges and related fi elds with a platform to initiate open, informed discussion and debate, and to 
identify and promote good practice in the development and delivery of needle exchange services.
www.inef.ie
drugnet 
IRELAND
21
NACD conference on drug use, sex work 
and risk
In order to discuss and disseminate the fi ndings of their 
recent report, Drug use, sex work and the risk environment in 
Dublin, the NACD held a half-day conference in June, chaired 
by Liam O’Brien, chairman of the NACD Consequences 
Sub-Committee. 
Opening the proceedings, Minister John Curran welcomed 
the report and the opportunity it gives to make informed 
decisions using evidence-based research. He promised a 
varied, inter-agency response to meet the range of issues 
faced by this vulnerable group.
Following a presentation of key fi ndings from the report 
by author Dr Teresa Whitaker, Dr Linda Cusick from the 
University of the West of Scotland spoke about sex-work-
related harm. She questioned the narrow defi nition of harm 
reduction often used in the drugs fi eld. When emphasis is 
placed on reducing harm to society, sex workers may feel 
targeted, and ‘that they are the harm to be reduced’. Dr 
Cusick believes that interventions must start by attempting 
to identify relevant harms (as in the NACD report), and aim 
to reduce these not only through conventional methods but 
by extending human rights to this hidden and stigmatised 
group. Social, family and education polices all have a role 
to play.
Dr Kathryn McGarry from Trinity College Dublin presented 
fi ndings from her research for a PhD thesis on the lived 
experiences of women in sex work. Risk emerged as a 
key concept in the course of this research. Dr McGarry 
highlighted the importance of the social networks of 
drug-using sex workers. Although not all women wish 
to collaborate with each other, and networks can expose 
them to harms such as needle sharing, peers are vital for 
risk management, working as look-outs to limit exploitation 
and educating (‘telling risks to’) each other. Peer-led harm 
reduction strategies therefore offer a positive and enabling 
resource for harm reduction efforts.
A range of voluntary and statutory agencies currently works 
closely with drug-using sex workers and the conference 
heard from representatives from the Women’s Health 
Project (Linda Latham), the Gay Men’s Health Service (Mick 
Quinlan), Chrysalis (Karen Murphy), and Novas (Mark Vella). 
These projects offer a range of health and social services that 
help drug-using sex workers minimise risk. The importance 
of outreach work to connect with all members of this 
community, and the challenge to reduce prejudice against 
this doubly stigmatised group, emerged as key themes.
(Mary Dunne)
The conference proceedings are available on the NACD 
website at www.nacd.ie.
continued funding of programmes (such as specialist  ■
CE schemes for drug users) aimed at getting drug users 
back to work; 
provision of fl exible hostel accommodation for drug- ■
using sex workers who are homeless, ranging from 
low-threshold facilities to accommodation that assists 
recovery and rehabilitation; 
recognition of the role of drug services in identifying  ■
male and female clients involved in sex work and in 
providing advice on safer sex practices in order to 
reduce sexual risk in personal intimate relationships and 
commercial sex transactions.
In terms of policy, the authors recommend that ‘harm 
reduction be explicitly stated as a guiding principle of the 
new National Drugs Strategy’ (p.26), and that the strategy 
must also outline a continuum of harm reduction activities, 
a ‘model package’ of interventions, minimum standards for 
services and optimal levels of service coverage.
Speaking at the launch of the report, John Curran TD, 
Minister with responsibility for drugs strategy, welcomed 
the research on this key ‘at risk group’, stating that it would 
inform developments in the new drugs strategy. He said he 
was committed to achieving real progress in harm reduction 
and drug rehabilitation, and acknowledged that signifi cant 
strides forward were needed across several areas, such as 
medical support, housing, education, employment and 
family support. 
(Mary Dunne)
1. Cox G and Whitaker T (2009) Drug use, sex work and 
the risk environment in Dublin, Dublin: National Advisory 
Committee on Drugs.
Drug-using sex workers  (continued)
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Review of progress in addressing 
suicide in Ireland
A Joint Oireachtas sub-committee was established in 2005 
to examine in detail the issue of suicide in Irish society; 
to engage with those who work in suicide prevention; 
and to hear evidence from those involved in post-suicide 
counselling and support. According to the World Health 
Organization, suicide is among the three leading causes 
of death worldwide among people in the 15–44-year-old 
age bracket. In 2004, there were 27.1 deaths/100,000 
population among men in Ireland, compared to 6.1 in 
England. For females the rate was 2.9/100,000 population, 
compared to 1.7 in England. Youth suicide rates in Ireland 
are the fi fth highest in the European Union. 
The sub-committee’s report, The high level of suicide in 
Irish society, was published in 20061 and accepted for 
implementation. It provided detailed information on 
the extent of suicide in Ireland and made 33 specifi c 
recommendations on how to address the problem. An 
updated report by a new sub-committee, published in June 
2009,2 reviewed the extent to which these recommendations 
have been implemented, and identifi ed the obstacles that 
have prevented their implementation (Table 1).
Very limited or no substantial progress was reported on 
implementing those recommendations dealing with the 
building of evidence around suicide through research and 
information gathering. These recommendations include 
agreement on a national programme of research into self-
harm, suicide and suicide prevention, the establishment 
of a technical group to link and exchange data between 
relevant national information systems, including the National 
Drug Treatment Reporting System and the National Drug-
Related Deaths Index, and the publishing of suicide research 
guidelines for donors providing funding. 
Similarly limited progress was reported regarding 
recommendations on making more information available 
to people at risk of suicide, to the general population, to 
specifi c groups such as school children, and to groups and 
individuals who could play a role in suicide prevention such 
as teachers, voluntary organizations, primary care teams and 
mental health staff. However, there was some progress in the 
organisation of consultation with young people and in the 
provision of information by primary care services to those 
bereaved by suicide.  
More progress was achieved in the development of services 
such as a pilot fast-track referral systems from primary care 
to mental health services for suicidal individuals and the 
development of a service plan for bereavement services. 
Other recommended services, including a coordinated 
response from various voluntary agencies working in the 
area of suicide bereavement support and a standardized 
pre-discharge and transfer between mental health services, 
have not been developed.
It appears that many of the recommendations outlined in 
2006 have not been progressed at all. In addition, the few 
recommendations that have been completed or mostly 
completed now need fi nancial resources and political drive 
in order to develop and implement their fi ndings. The 
report concludes that immediate change is required to 
properly address the ongoing serious problem of suicide 
in Ireland. The National Offi ce for Suicide Prevention 
needs adequate and sustained funding, a higher level 
of interagency collaboration, and the requisite political 
support if it is to have any chance of fully implementing the 
recommendations made in the 2006 Oireachtas report. 
(Deirdre Mongan)
1. Joint Committee on Health and Children (7th Report) 
(2006) The high level of suicide in Irish society. Dublin: 
Houses of the Oireachtas.
2. Joint Committee on Health and Children (2009) The high 
level of suicide in Irish society. First report. Dublin: Houses 
of the Oireachtas.
National Registry of Deliberate Self 
Harm annual report 2008
The seventh annual report from the National Registry of 
Deliberate Self Harm was published in July 2009.1 The 
report contains information relating to every presentation 
of deliberate self-harm to hospital A&E departments in 
2008, giving complete national coverage of hospital-
treated deliberate self-harm. The Registry defi nes deliberate 
self-harm as ‘an act with non-fatal outcome in which an 
individual deliberately initiates a non-habitual behaviour, 
that without intervention from others will cause self-harm, or 
deliberately ingests a substance in excess of the prescribed 
or generally recognised therapeutic dosage, and which is 
aimed at realising changes that the person desires via the 
actual or physical consequences’. 
According to the report, there were 11,700 presentations 
of deliberate self-harm, involving 9,218 individuals, to A&E 
departments in 2008. Reviewing data for the six-year period 
2002–2007, the report indicates that the rate of presentation 
was relatively stable. However, a 6% increase was noted in 
the national person-based rate per 100,000, which rose from 
188 in 2007 to 200 in 2008.
The biggest rise in deliberate self-harm was observed in 
men, an increase of 11% on the 2007 fi gure, resulting in the 
highest rate since the Registry was established in 2002. Men 
accounted for 45% and women for 55% of deliberate self 
harm episodes in 2008.
Concordant with previous reports, deliberate self-harm was 
largely confi ned to the younger age groups. Almost half of 
all presentations (46.5%) were by people aged under 30 
years. The peak age ranges for females and males presenting 
were the same as in previous years, at 15–19 years for 
females and 20–24 years for males. There was an increase in 
the number of 10–14-year-olds presenting.
drugnet 
IRELAND
23
National Registry report  (continued)
Rates were higher in urban settings, with the highest rate 
(17%) presented in Dublin North East Hospital Group. The 
number of presentations was highest on Mondays and 
Sundays, accounting for one in three of all presentations. 
Over 40% of all presentations were made between the hours 
of 8 pm and 3 am.
Repetition of deliberate self-harm accounted for more than 
one in fi ve (21%) of all presentations in 2008, and the 
highest proportion of repeated acts was among the 30–40-
year age group. 
Drug overdose was the most common form of deliberate 
self-harm, representing 72% of all such episodes reported 
in 2008. Overdose rates were higher among females (79%) 
than among males (64%). On average, at least 31 tablets 
were taken in episodes of drug overdose. The total number 
of tablets taken was known in 74% of cases. Forty-one per 
cent of all drug overdoses involved a minor tranquilliser, 
23% involved paracetamol-containing medicines and 22% 
involved anti-depressants/mood stabilisers. The report 
points out that, despite its withdrawal from the Irish market 
in January 2005, the analgesia, distalgesic, was involved 
in 29 cases of deliberate self-harm in 2008, this compared 
to approximately four hundred cases reported annually 
between 2002 and 2005. 
There was evidence of alcohol consumption in 42% of all 
episodes of deliberate self-harm, emphasising the strong 
association between alcohol consumption and suicidal 
behaviour. Illicit drugs such as cocaine and heroin were 
involved in 3.8% of all overdose acts.
Attempted hanging was more often used as a method 
of deliberate self-harm in 2008 than in previous years, 
accounting for 16% of all self-harm acts in the 10–14-year 
age group. Self-cutting represented 21% of all episodes of 
self-harm, and was more common among males (25%) than 
among females (18%).
The emergency department was the only treatment setting 
for more than half (57%) of all deliberate self-harm patients, 
that is, they did not proceed to further treatment.
The report recommends the following measures to reduce 
the incidence of deliberate self-harm:
Provide continued support for the national mental  ■
health awareness campaign and evidence-based mental 
health promotion initiatives and implementing more 
intensifi ed prevention and intervention programmes at 
national level.
Develop and implement initiatives to increase awareness  ■
of mental health issues among the general public and 
service providers supporting the unemployed or people 
experiencing fi nancial diffi culties.
Develop a system to enable deliberate self-harm data  ■
to be linked with suicide mortality data to improve our 
understanding of risk factors associated with suicide.
Prioritise evidence-based mental health programmes for  ■
children and adolescents, in addition to specialist mental 
health services.
Develop more uniform assessment procedures and  ■
evidence-based interventions targeting people who 
repeatedly self-harm.
Restrict or withdraw highly lethal drugs from the market. ■
Verify whether interventions such as cognitive  ■
behavioural and problem-solving treatments found to be 
effective among women can be equally so among men 
presenting with deliberate self-harm.
(Ena Lynn)
1. National Registry of Deliberate Self Harm Ireland (2009) 
Annual report 2008. Cork: National Suicide Research 
Foundation.
Poisons Information Centre annual 
report 2008
The Poisons Information Centre, located in Beaumont 
Hospital, is the national information service providing 
advice on the features and management of poisonings. This 
service is provided 24 hours a day 365 days a year and is 
offered mainly to heath care professionals. Queries are dealt 
with by poison information offi cers at the Centre between 
8 am and 10 pm; out–of-hours enquiries are re-directed to 
the UK National Poisons Information Service (NPIS). The 
2008 report includes analysis of all enquiries made to the 
centre, including, for the fi rst time, Irish calls handled by 
the UK service.1
In 2008 the centre received 10,494 enquires, a reduction of 
4.7% on the 2007 fi gure. An average of 28 calls a day was 
received, with a peak call time between 6 pm and 9 pm. 
There were 9,911 (94.4%) enquires in relation to poisoning 
in humans, 442 (4.2%) in relation to poisoning in animals, 
and 141 (1.3%) general enquiries. Enquiries were mainly 
from hospitals (38%), general practitioners (35%) and 
members of the public (22.1%).
Of the enquiries relating to poisoning in humans, 4,985 
(50.3%) involved children under 10 years old, with a peak 
age of one to four years [4,087 (41.2%)]. The majority of 
incidents occurred in the home (89.9%). In the total of 
9,911 enquiries involving human poisoning, 16,936 agents 
were involved. The most common substances taken were 
paracetamol, ibuprofen and codeine. Ethanol was ingested 
in 634 cases, often in combination with another substance. 
The majority of cases, 5,681 (57.3%), were reported as 
accidents, while a quarter, 2,491 (25.1%), were classed as 
intentional poisoning or recreational abuse. The remainder 
were classed as therapeutic error, adverse reaction, other 
and unknown.
(Simone Walsh)
1. Poisons Information Centre of Ireland (2009) Annual 
Report 2008. Dublin: Poisons Information Centre. 
www.poisons.ie
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A training programme in dual diagnosis
The clinical nurse specialist (CNS) in addictions based in 
the Central Mental Hospital in Dublin has played a key role 
in developing a pathway of therapeutic group programmes 
for people with a dual diagnosis of mental illness and 
substance abuse.
Dual diagnosis is a very recent concept in the Irish 
mental health service. The concept was highlighted 
by MacGabhann and colleagues,1 who recommended 
incorporating training for dual diagnosis into undergraduate 
and continuing education programmes for those working in 
addiction and mental health services. Because such training 
is not widely available in Ireland, an innovative fi ve-day 
training programme was developed by Hanora Byrne, CNS 
in addictions at the Central Mental Hospital, and Dr Shobha 
Rani, lecturer in nursing at Trinity College Dublin. The 
programme has been awarded category 1 approval by An 
Bord Altranais.
The programme development was based on a six-step 
approach devised by Kern and colleagues.2 The six steps 
are: problem identifi cation, needs assessment, objectives, 
implementation, educational strategies and evaluation. 
Analysis of a needs assessment involving 20 psychiatric 
nurses and 20 probation offi cers showed that it was clearly 
necessary to develop a training programme in dual diagnosis. 
The main objectives of the programme were to provide 
information on dual diagnosis and the treatment 
programmes that can be applied in service delivery. The 
programme has four modules delivered through lectures, 
group discussions, role play, video recording and feedback, 
and vignettes. A workbook was developed to accompany the 
delivery of the training.
The fi rst training programme was run on one day a week 
for fi ve weeks at the end of 2008. It was delivered by the 
CNS and members of the multidisciplinary teams within the 
Central Mental Hospital, including Prof Harry Kennedy, the 
clinical director, and Paul Braham, the director of nursing. 
Participants were assessed using formative evaluation 
tools, such as questions and answers and three short 
written assignments. The course was evaluated using the 
following: pre- and post-test evaluation, daily evaluation by 
the participants, and a focus group carried out 12 weeks 
after the course completion. The programme co-ordinators 
envisage running an annual one-day refresher course.
The next training programme is scheduled for early October 
2009 in the National Forensic Mental Health Service, 
Central Mental Hospital, Dundrum, Dublin 14. For more 
information, contact Hanora Byrne at 01-2157556; email: 
hanora.byrne@hse.ie
(Hanora Byrne)
1. MacGabhann L, Scheele A, Dunne T et al. (2004) Mental 
health and addiction services and the management of dual 
diagnosis in Ireland . Dublin: Stationery Offi ce.
2. Kern D, Thomas P and Howard D (1998) Curriculum 
development for medical education: a six-step approach. 
Baltimore, MD: Johns Hopkins University Press.
Identifying new drugs and drug trends 
with the help of drug helplines
In July 2009 the European Foundation of Drug Helplines 
(FESAT) published the results from the 15th and 16th data 
collections for its monitoring project.1,2 Since the beginning 
of 2001 FESAT has been collecting information every six 
months on the types of person contacting helplines, the 
content of these calls and how this has changed compared 
to the previous six months. According to the author, 
the main objective of this monitoring is to identify the 
emergence of new drugs and new drug trends; the data 
cannot quantify the size of any such changes.
Of the 34 relevant FESAT helplines, 14 helplines in 11 
countries, including Ireland, participated in the project in 
the fi rst half of 2008. This article outlines some of the main 
changes reported for the fi rst half of 2008 when compared 
to the second half of 2007, and presents some unpublished 
information from the Drugs/HIV Helpline in Ireland.
The smallest of the 14 participating helplines in Europe 
answered less than one call per day, and the largest, more 
than 60 calls per day. Seven helplines answered 10 calls or 
fewer per day; six helplines answered 11 to 30 calls; one 
helpline answered 31 to 60 calls and one helpline answered 
61 or more calls. Half of the helplines answered 13 or more 
calls per day. The Drugs/HIV Helpline in Ireland answered 
an average of 14 calls per working day, though this fi gure 
included calls about sexual health. There were 1,805 calls 
between January and June 2008, which represents an 8% 
decrease when compared to the preceding six-month 
period. This decrease was expected due to the fact that 
there was an increase in the number of calls during the 
pharmacy strike in October 2007 (Aileen Dooley, personal 
communication, 2009).
The FESAT report notes a decline in the numbers of 
helplines reporting calls about crack (9 helplines), heroin 
(6 helplines), ecstasy (6 helplines), cocaine (4 helplines) 
and hash (4 helplines) across Europe in the fi rst half of 
2008 when compared to the second half of 2007, and an 
increase in the number of helplines reporting calls about 
alcohol (10 helplines) and medications (other than opiates 
and benzodiazepines) (7 helplines) and benzodiazepines 
(4 helplines). There were mixed reports about cocaine and 
cannabis across Europe, with some helplines reporting 
increases and some reporting decreases.
In Ireland, there were large decreases in the number of calls 
to the Drugs/HIV Helpline about hashish and painkillers 
containing opiates in the fi rst half of 2008 when compared 
to the second half of 2007. There were large increases in the 
number of calls about alcohol, cocaine, ecstasy and smoking 
heroin (Aileen Dooley, personal communication, 2009).
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The Drugs/HIV Helpline in Ireland is a confi dential, 
freephone, active listening service offering non-directive 
support, information, guidance and referral to anyone 
with a question related to substance use or HIV and 
sexual health. Set up in July 1997, the service is funded 
and managed by the Health Service Executive. The 
freephone number is 1800 459 459. The Helpline 
manager is Aileen Dooley.
During the fi rst half of 2008, a number of helplines in Europe 
received calls about drugs that had not been reported to 
them before. Helplines in Belgium and in Germany reported 
calls about the ‘spice’ products which are used to induce the 
same effect as cannabis. A helpline in Belgium received calls 
about ‘space shuttles’, which are in the form of mushrooms 
or herbs. A helpline in Norway received its fi rst call about 
mescaline, a hallucinogenic drug.
(Jean Long)
1. Evenepoel T (2009) FESAT Monitoring Project  – Report 
on the 15th data collection: changes during the second half 
of 2007. Brussels: FESAT (The European Foundation of 
Drug Helplines). 
2. Evenepoel T (2009) FESAT Monitoring Project  – Report 
on the 16th data collection: changes during the fi rst half of 
2008. Brussels: FESAT (The European Foundation of 
Drug Helplines). 
More information about FESAT can be found at www.fesat.org.
Identifying new drugs  (continued)
Ana Liffey’s SMS service for drug users
On 30 June 2009 the Ana Liffey Drug Project launched the 
‘Duck, Dive and Survive’ SMS service. This service enables 
Ana Liffey to offer real time information on reducing the risks 
associated with drug use and provide essential health and 
service-related information. There is a high rate of mobile 
telephone use among Ana Liffey’s clients and this innovative 
approach adopts this technology to communicate with 
people who use drugs.
Ana Liffey used the special bursary it received as winner of 
the New Initiatives category of the Crystal Clear MSD Health 
Literacy Award 2009 to establish the service. 
Information provided by SMS includes:
changes to opening times of key services; ■
advice on overdose risks and prevention, particularly  ■
during festive/holiday periods which Ana Liffey suspects 
are times when overdoses are more likely;
new trends and dangers relating to illicit drug use – the  ■
North Inner City Drugs Task Force will use the SMS 
service to get key information to service users;
information from service users – Ana Liffey works with  ■
the service users’ ‘Peer Support Group’ to identify key 
messages to be sent to their peers.
An example of a group text message sent to people who 
attended the Ana Liffey project during June 2009 is:
OVERDOSE: Don’t panic. Put them in the recovery 
position, dial 999, ask for an ambulance and stay 
with them until the ambulance arrives. Ana Liffey: 
1800786828
Following feedback from service users, the providers of the 
service realised that, to be effective, the messages sent must 
get to the point quickly and should ideally name the issue 
and the action to be taken. Messages can be no more then 
160 characters (including spaces) to allow for the message 
to be sent in one go. Messages can be personalised by 
having the person’s fi rst name appear at the beginning of 
the text, but this also uses up text characters. 
A total of 2243 text messages were sent during the fi rst 13 
weeks after the launch of the service, and by mid-August 73 
Ana Liffey service users had signed up. 
The Swansea Drugs Project (Wales) has followed the 
example of the ’Duck, Dive and Survive‘ SMS service and 
they are establishing an SMS service of their own.
To date, messages have been developed in a reactive way, 
addressing issues identifi ed by the Ana Liffey team and 
external issues affecting the client group. A reactive service 
is necessary, and is one of the strengths of such a mass 
communication tool. However, the next phase of SMS 
delivery will involve the development of targeted health 
campaigns sent at strategic times. This campaign will build 
on the success of the texts as developed to date.
(Tony Duffi n (ALDP) and Brian Galvin)
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New NDC website
The National Documentation Centre on Drug Use (NDC) 
launched its new website in July. The NDC adapted Eprints, 
an application used to develop research repositories in 
universities around the world, to create the new system. It 
allows the NDC to integrate all its digital collections in one 
easily searchable database. 
The new site www.drugsandalcohol.ie is a repository of 
Irish research outputs in alcohol and drugs. Any of the 
repository’s 1,000 documents or the 7,000 news items, 
bibliographical records and reports of parliamentary debates 
can be retrieved using a simple search function. 
Regularly updated news stories and records of new library 
acquisitions are available on the home page, and various key 
resources, including the annual national report on the drug 
situation in Ireland, fact sheets and the NDC newsletter, are 
made available with just one click on links on the home page.
Visitors can search the entire website using a simple search 
function on the home page or, for more experienced 
users, an advanced search can be used for more refi ned 
searching. The search result displayed below shows how the 
repository's records and full text material are presented after 
a search.
One of the key aims of Ireland’s National Drugs Strategy 
2001–2008 was to make available ‘valid, timely and 
comparable data on the extent and nature of drug misuse 
in Ireland’. It is important that high-quality research 
information is made accessible to, and informs the work 
of, policy-makers, service planners and service providers. 
The NDC’s new website will help to strengthen its 
contribution to this process of knowledge transfer 
during the implementation of the new drugs strategy.
(Brian Galvin)
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In brief
On 24 April 2009 Fear of crime in Ireland and its impact 
on quality of life was published by the Department of 
Justice, Equality and Law Reform. The research had been 
commissioned by the former National Crime Council.1 The 
authors reported that a relationship was found between illicit 
drugs and concerns and fear about lawlessness and crime. 
They also observed a relationship between fear of crime and 
perceptions regarding the penalties for possession of ‘soft’ 
and ‘hard’ drugs, and between fear of crime and respondents’ 
beliefs regarding how drug abuse and juvenile crime should 
be dealt with. www.justice.ie 
On 13 May 2009 the Economic and Social Research 
Institute published Investing in education: combating 
educational disadvantage (Research Series No 6). The 
fi ndings show that education is highly predictive of individual 
life-chances in Ireland: a Leaving Certifi cate qualifi cation has 
become the ‘minimum’ to secure access to further education/
training and high quality employment, among other 
outcomes. www.esri.ie 
On 13 May 2009 the Health Service Executive published 
LGBT health: towards meeting the health care needs of 
lesbian, gay, bisexual and transgender people, a report of 
the fi ndings from a mapping exercise undertaken for the 
HSE national social inclusion governance group. The report 
highlighted particular health issues experienced by the LGBT 
population, including the health impacts of higher levels 
of smoking, alcohol consumption and recreational drug 
use. A high incidence of mental health problems, including 
depression, anxiety, substance misuse, self-harm and suicide, 
was also reported. www.hse.ie
On 14 May 2009 the Report of the Inspector of Mental 
Health Services for 2008 was published, together with 
the Annual Report of the Mental Health Commission 
for 2008. The Inspector reported that the management of 
alcohol-related problems was inconsistent: some consultant 
psychiatrists saw it as the function of the Mental Health Service 
to provide detoxifi cation, whereas best practice would indicate 
that this should be carried out either in general hospitals or 
in primary care. Despite absence of an evidence base that 
residential alcohol treatment is more successful than outpatient 
programmes, many centres continued the ‘resource-sapping’ 
practice of hospitalisation. With regard to addiction psychiatry, 
the Inspector wrote that there is a clear need for mental 
health professionals to become and remain well versed in the 
problems associated with substance dependence, and identify 
and refer to the addiction services those patients where this is 
the primary problem. www.mhcirl.ie 
On 21 May 2009 the National Commission on Restorative 
Justice published its Interim Report. The Report examines 
how restorative justice is applied in Ireland and in other 
jurisdictions and points to the research-based evidence 
abroad on the potential of restorative justice to combat 
crime. The Commission is due to publish its fi nal report, with 
recommendations, later in 2009. www.justice.ie 
On 26 May 2009 foetal alcohol spectrum disorders were 
the subject of an adjournment debate in Dáil Éireann. 
Deputy Áine Brady stated that, in order to create greater 
awareness of the risks, the Health Service Executive (HSE) has 
published a booklet entitled Women and alcohol, including 
advice to women to avoid alcohol in pregnancy, and the 
Department of Health is devising legislation to provide for 
mandatory labelling of alcohol containers advising of the 
risk of consuming alcohol during pregnancy. The HSE is also 
developing proposals for a new research project in a large 
maternity hospital to follow a cohort of women who drink 
alcohol during pregnancy in order to evaluate the impact on 
the infant’s condition at birth and subsequent development. 
(www.oireachtas.ie) 
On 10 July 2009 the 2008 Annual Report from the Alcohol 
Marketing Communications Monitoring Body (AMCMB) 
was published. The AMCMB was established to monitor the 
level of adherence by advertisers and media owners to the 
Codes of Practice on Alcohol Marketing, Communications and 
Sponsorship. The Codes are intended to limit the exposure 
of children and young people to alcohol advertising in 
Ireland. The AMCMB concluded that there had been overall 
compliance in 2008. However, noting a number of breaches, 
it considered that the media partners to the Codes should 
ensure that they have proper procedures in place to prevent 
breaches occurring. www.dohc.ie 
On 14 July 2009 the Irish Youth Justice Service (IYJS) 
published Designing effective local responses to youth crime: 
a baseline analysis of the Garda Youth Diversion Projects. The 
fi rst part of an improvement programme for Garda Youth 
Diversion Projects, this baseline analysis provides a qualitative 
profi le of youth crime in each locality and analyses the way 
that Garda Youth Diversion Projects intend to effectively 
impact upon youth offending. Currently there are 100 projects 
located around the country, representing a €13 million 
investment annually in youth crime prevention. www.iyjs.ie 
On 23 July 2009 the Courts Service annual report for 2008 
was released. It reported among other matters that drug 
offence cases before the District Court had increased by 
58% – to 15,658 from 9,870 in 2007 – and that 18% of cases 
before the Circuit Court were for drug offences. www.courts.ie 
In July 2009 three new pieces of criminal justice legislation 
were enacted targeting organised crime:
Criminal Justice (Miscellaneous Provisions) Act 2009 ■  makes 
provision for a statutory framework for the licensing of 
fi rearms, including handguns, which seeks to halt the 
emergence of a gun culture in Ireland. 
Criminal Justice (Amendments) Act 2009 ■  provides for 
additional measures with respect to combating organised 
crime and, in particular, with respect to countering the 
increased levels of violence towards, and intimidation 
of, members of the public perpetrated by criminal 
organisations and securing conditions in which offences 
committed by those associated with such organisations 
can, in due course of law, be investigated and prosecuted, 
and to amend the law in relation to the investigation of 
offences, including in relation to the detention of suspects 
and their re-arrest in certain circumstances, and to 
otherwise amend criminal law and procedure.
Criminal Justice (Surveillance) Act 2009 ■  provides for a 
statutory framework for evidence obtained using covert 
surveillance which is to be used in criminal trials. It gives 
the Garda, Defence Forces and the Revenue a legal basis 
for surveillance to combat serious criminal, subversive or 
terrorist activity, and provides for a judicial authorisation 
procedure for surveillance. www.justice.ie 
(Compiled by Brigid Pike)
1. The National Crime Council ceased operations in October 
2008.
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CLAT 5: Globalisation, harm reduction and human rights
Article by Dagmar Hedrich in Drugnet Europe No. 67, 
July–September 2009
Over the last two decades, harm reduction has become 
a recognised component of a comprehensive approach 
to drugs. Examining its future and taking stock of 
achievements was the focus of the 5th Latin conference on 
harm reduction (CLAT 5),1 held in Oporto from 1–4 July. 
Organised in association with the EMCDDA, the conference 
brought together over 600 participants from Europe and 
the Americas to debate the theme ‘Globalisation, harm 
reduction and human rights’.
Speakers at the event provided critical analyses of the 
benefi ts brought by harm reduction interventions to 
individuals and society to date. While acknowledging 
progress, they questioned the current consensus that policies 
and practice be rooted largely in public health concerns and 
restricted to local micro-interventions aimed at reducing the 
health risks of drug use. Central to the debate was the need 
for harm reduction also to address more global concerns 
such as discrimination, vulnerability and inequality (North–
South, East–West), which are often key factors underlying 
drug problems. It was argued that the risks associated with 
drug use were often more linked to social, cultural and 
historical conditions than to the substances themselves. By 
setting in the context of human rights our current responses 
to drug production, traffi cking, consumption and harm, 
the debate was given an important new dimension and its 
horizons were broadened well beyond Europe. 
1. CLAT is the result of collaboration between fi ve countries: 
Spain, France, Italy, Portugal, Switzerland. 
www.clat5.org/en/clat5_objective.php
Annual KBS symposium
Article by Linda Montanari and Margareta Nilson in Drugnet 
Europe No. 67, July–September 2009 
Alcohol-related harm, drinking practices and social and 
institutional responses were among the issues discussed 
at the 35th annual alcohol epidemiology symposium of the 
Kettil Bruun Society (KBS), held in Copenhagen from 1–5 
June. KBS is an organisation of scientists which promotes 
social and epidemiological research on alcohol and 
fosters a comparative understanding of alcohol use and 
related problems. 
Although alcohol is the main focus of the event, space is 
also allocated to quantitative and qualitative research on 
other substances, such as tobacco and illicit drugs, including 
polydrug use. On the latter, the EMCDDA presented 
European data on polydrug use among clients in treatment, 
which confi rm that alcohol is most often reported as the 
secondary substance used in combination with other drugs. 
The EMCDDA stressed the need to consider the health and 
social consequences of polydrug use when planning policy 
and interventions and the importance of improving the 
quality of polydrug use data at European level. 
www.kbs2009.dk/abstracts-kbs2009.pdf
Drugs in focus – policy brieﬁ ng
Drugnet Europe is the quarterly newsletter of the 
European Monitoring Centre for Drugs and Drug 
Addiction (EMCDDA). Drugs in focus is a series of policy 
briefi ngs published by the EMCDDA. Both publications 
are available at www.emcdda.europa.eu.
If you would like a hard copy of the current or future 
issues of either publication, please contact: Alcohol and 
Drug Research Unit, Health Research Board, Knockmaun 
House, 42–47 Lower Mount Street, Dublin 2. Tel: 01 
2345 127; Email: adru@hrb.ie.
No. 19: Neurobiological research on drugs: ethical and 
policy implications
Most neurobiological research to date has focused on the 
fact that addictive drugs increase the release of dopamine, 
a neurotransmitter which helps individuals memorise signals 
of pleasure or ‘reward’. New fi ndings suggest that serotonin 
and noradrenaline (which work as a couple controlling 
impulsivity and asserting vigilance) are also involved in the 
addiction process. This briefi ng describes how chronic drug 
use disrupts this coupling, making a person more prone to 
cravings and less capable of controlling consumption.
The briefi ng concludes with a series of policy considerations:
Neuroscience has the potential to improve our 1. 
understanding of addiction, possibly leading to new forms 
of treatment. There is a need to continue supporting 
studies in this area, whilst reviewing how European 
research can be encouraged and best organised.
The assumption that repeated consumption of drugs 2. 
of abuse induces long-term modifi cations in cerebral 
neurotransmission presents a strong argument for 
research aimed at characterising these modifi cations and 
fi nding ways to reverse them.
New methodologies such as neuroimaging and genetic 3. 
research may help to better understand variations in 
vulnerability to addiction, even if social factors are also 
clearly important. However, the extent to which this can 
be used in practice remains questionable.
The effi cacy of novel immunological approaches and 4. 
neurological techniques will require detailed scrutiny. 
Some approaches in this area may be used in ways that 
raise important ethical and social concerns which could 
offset, or even be greater than potential benefi ts.
Neurobiological research provides support for a ‘medical 5. 
model’ of addiction. However, many drug issues 
concern the non-dependent use of illicit substances 
and the question of which approaches are appropriate 
to encourage addicted individuals into treatment — 
particularly those who may not want to be treated — is 
a critical one.
From Drugnet Europe
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A major challenge for policy will be to fi nd ways to 6. 
educate the public about the neurobiological basis of 
addiction, whilst acknowledging that individual and 
social choices also impact on drug use and addiction.
These issues are addressed in a new EMCDDA monograph: 
Carter A, Capps B and Hall W (eds) (2009) Addiction 
neurobiology: ethical and social implications. Monograph 
No. 9. Luxemburg: Offi ce for Offi cial Publications of the 
European Communities.
Drugs in focus  (continued)
Drug use: an overview of general 
population surveys in Europe
The EMCDDA recently published an overview of general 
population surveys on the prevalence of drug use in Europe.1 
The authors conducted a meta-analysis of the national 
surveys in use in 18 countries since 2001 and compared the 
different survey methods used.
The participating countries provided information about their 
national surveys under four headings: the intrinsic focus 
(design of the questionnaire and type of questions asked), 
the methodology used, fi nancial issues, and the utility and 
accessibility of the results. The overview identifi ed intrinsic 
and methodological issues relating to the comparability of the 
national surveys and the standardisation of defi nitions used, 
some of which are outlined below.
The surveys in many countries comply, wholly or in part, 
with the European Model Questionnaire (EMQ), which 
allows cross-country comparisons. However, not all countries 
conduct surveys specifi cally on drug use. Some include 
drug-related questions in general health or crime surveys, 
which limits the number of drug-related questions that can 
be asked. This means that the surveys conducted in different 
countries vary in the number of items and the number of 
questions included. 
While most countries want to include in their surveys 
questions about all the psychoactive drugs that are known to 
be used, it is recognised that estimates obtained in this way 
actually underestimate the use of some drugs in the general 
population. 
Most national surveys include three prevalence indicators 
for each drug included: lifetime use, last year use and 
last month use. However, some countries feel that these 
prevalence rates must be interpreted with caution because 
of the low number of users among the general population. 
Measuring the prevalence of misuse of licit drugs tends to be 
limited. 
The authors report that countries are divided on the 
inclusion of an item on intravenous drug use in their surveys. 
The argument against including such an item is, again, 
linked to the low prevalence in the general population and 
the belief that such users, if reached, would not be willing to 
reply to the questionnaire.
The authors found no consensus about the measurement 
of the frequency of use of either licit or illicit drugs. Several 
countries, including Ireland, measure frequency of use in 
the last month only as they feel that is the most useful recall 
period; other countries are of the opinion that the sample 
size for last-month frequency tends to be too small, and 
therefore also measure lifetime and last-year frequency.
A high response rate is generally seen as a mark of quality 
in a survey. The rates reported in this overview ranged from 
21% in Austria to 91% in Hungary. Information on how 
non-response rates are calculated is often not reported. The 
authors suggest that standardised defi nitions and formulas 
for calculating response rates be provided so that better 
cross-survey comparisons can be made. 
Securing funding to repeat surveys is a major problem for 
some countries and leads to restrictions on the length of the 
questionnaire and the sample size. The authors noted that 
most national survey reports do not contain any information 
about the costs of the survey. 
In conclusion, the authors suggest that some of the 
intrinsic and methodological issues should be standardised 
to improve comparability of general population surveys 
across Europe. 
(Suzi Lyons)
1. Decorte T, Mortelmans D, Tieberghien J and De Moor S 
(2009) Drug use: an overview of general population surveys 
in Europe. Luxembourg: Offi ce for Offi cial Publications of 
the European Communities.
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Recent publications
Journal articles
The following abstracts are cited from recently published 
articles relating to the drugs situation in Ireland.
Youth alcohol and drug use in rural Ireland - parents’ views 
Van Hout MC
Rural and Remote Health 2009; 9: 1171
Introduction: Drug availability is increasing throughout 
Ireland due to a convergence of rural and urban cultures 
during the last decade of economic growth and prosperity. 
Rural Irish youth may now have a heightened risk for 
problematic alcohol and drug use due to increased exposure 
to drugs, urban contact with peer drug users, unstructured 
recreation time and poor parental monitoring. Rural parents 
may perceive their children to be less at risk, and often 
struggle more than their urban counterparts to identify and 
respond to their children’s alcohol and drug use. The aim of 
this research was to provide an exploratory account of rural 
parents’ perspectives on alcohol and illicit drug use among 
youth in Ireland.
Methods: A convenience sample of parents with adolescent 
children was selected at a parent–teacher evening at three 
rural schools, with the facilitation of school completion 
offi cers (34 mothers and 21 fathers). Semi-structured 
interviews were conducted, which included questions relating 
to the parents’ perceptions of youth drug and alcohol use, 
both in terms of recreational and problematic use in their 
communities, levels of drug availability, risk perceptions, 
settings of adolescent substance use, service provision and 
drug information. Following transcription of the interviews, 
a content and thematic analysis was conducted in order to 
identify areas of similar and contrasting opinions, and various 
formulations were compared and contrasted in order to 
ground the information fi rmly in the data garnered.
Results: The results suggested parental concern with 
regard to increased drug exposure for youth in local rural 
communities. The majority of parents were aware of youth 
alcohol use but were concerned about all drugs, were not 
aware of specifi c differences in drug-related risk, and had 
diffi culty comprehending harm-reduction principles. Most 
parents recognised the need for greater parental monitoring, 
awareness of free-time accountability, improved parent–child 
discourse, and visibility of services.
Conclusion: Life in contemporary rural Ireland is infl uenced 
by dominant social changes in terms of the normalisation of 
alcohol and drug use in youth subcultures, with increased 
fragmentation of traditional rural family norms and values, 
emerging acceptability of alcohol and drug use in recreation 
time and widespread availability of alcohol and drugs. 
There is a need to target rural parents using a community 
development approach in order to provide drug education, 
service visibility and family support for those experiencing 
problematic substance use.
Is the contribution of alcohol to fatal traumatic brain 
injuries being underestimated in the acute hospital setting? 
O’Toole O, Mahon C, Lynch K and Brett FM
Irish Medical Journal 2009; 102 (7): 207–209
Alcohol consumption in Ireland almost doubled during the 
period 1989–2001. To evaluate the relationship between 
alcohol and fatal head injuries in the acute hospital setting, 
we created a database of all fatal traumatic brain injuries in 
the Department of Neuropathology at Beaumont Hospital 
over a ten-year period (1997–2006 inclusive); 498 cases were 
identifi ed (351 males and 147 females). 
Fatalities were highest in males aged 19–25 years (n =101) 
and 51–70 years (n =109). Falls (n =210) and road traffi c 
accidents (RTAs) (n =183) were the commonest modes of 
presentation. Of the cases involving a fall, 36 (17%) had 
positive blood alcohol testing, 9 (4.3%) had documentation 
of alcohol in notes but no testing, 35 (16.7%) tested negative 
for alcohol, and 130 (61.9%) were not tested. The RTA group 
comprised drivers (n =79), passengers (n =47) and pedestrians 
(n =57). Of the drivers, 65/ (82.2%) were males aged 19–25 
years. Blood alcohol was only available in 27/79 (34.1%) 
drivers and was positive in 13/27(48.1%). Of the pedestrians, 
14 (18.7%) were tested for alcohol, of whom 4 (28.6%) were 
positive. Overall, 142/183 (77.6%) of the RTA group were not 
tested. The contribution of alcohol to fatal traumatic brain 
injuries is probably being underestimated due to omission of 
blood alcohol concentration testing on admission to hospital. 
Absence of national guidelines on blood alcohol testing in the 
emergency department compounds the problem.
Prevalence of problem alcohol use among patients 
attending primary care for methadone treatment
Ryder N, Cullen W, Barry J, Bury G, Keenan E and Smyth B
BMC Family Practice 2009; 10 (42)
Background: Problem alcohol use is associated with adverse 
health outcomes among current or former heroin users 
and primary care is providing methadone treatment for 
increasing numbers of this population. This study aimed to 
determine the prevalence of problem alcohol use among 
current or former heroin users attending primary care for 
methadone treatment and to describe the socio-demographic 
characteristics and health service utilisation characteristics 
associated with problem alcohol use.
Methods: We conducted a cross sectional survey of patients 
sampled from a national database of patients attending 
general practice for methadone treatment. Participants 
were recruited by their general practitioner and data were 
collected using an interviewer-administered questionnaire, 
which included the Alcohol Use Disorders Identifi cation 
Test (AUDIT), with a score of >7 considered abnormal, i.e. 
‘AUDIT-positive cases’ and socio-demographic, medical and 
substance-use characteristics.
Results: We interviewed 196 patients (71% of those invited, 
31% of those sampled, 11% of the national database). 
The median age was 32 years, 55% were hepatitis C positive, 
79% had used illicit drugs in the previous month and 
68% were male. Sixty-eight AUDIT-positive cases were 
identifi ed (prevalence of 35%, 95% CI = 28–41%) and 
these were more likely to have attended a local emergency 
department in the previous year (p < 0.05) and less likely to 
have attended a hospital clinic in the previous year (p < 0.05). 
Twenty-seven (14%) scored 20 or higher, indicating possible 
alcohol dependence.
Conclusion: Problem alcohol use has a high prevalence 
among current or former heroin users attending primary 
care for methadone treatment and interventions that address 
this issue should be explored as a priority. Interventions 
that address problem alcohol use in this population should be 
considered as a priority, although the complex medical 
and psychological needs of this population may make 
this challenging.
(Compiled by Louise Farragher)
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Upcoming events
(Compiled by Louise Farragher – lfarragher@hrb.ie)
September
24–25 September 2009
European Commission Conference: Bridging the Research 
Gap in the Field of Illicit Drugs in the EU
Venue: Albert Borschette Conference Centre, Brussels
Organised by / Contact: European Commission 
(Directorate General for Justice, Freedom and Security)
www.illicitdrugsresearch.eu
Information: To be opened by Jacques Barrot, vice 
president of the European Commission, the conference 
will take stock of research in the fi eld of illicit drugs in 
the EU, looking at future research needs and at how EU 
co-ordination and co-operation could be improved to 
strengthen research capacity in this fi eld. To do this, the 
conference will bring together some 200 policy makers, 
researchers, and research funding organisations from across 
the EU, together with representatives from international 
organisations and EU institutions. 
A number of places are reserved for invited participants; 
however, we encourage active participation, in particular 
by researchers in the illicit drugs and related fi elds; research 
councils and/or funding agencies already involved in the 
funding of drug-related (or addiction) research, or interested 
in doing so in the future; and other stakeholders that play an 
important role in illicit-drug-related research.
If you would like to participate in this event, please pre-
register on-line. Closing date for registration is Friday, 18 
September. Your registration will be subject to agreement 
by the Commission and will be confi rmed by our contractor 
TIPIK. Participation may have to be restricted due to the 
limited number of places available. Participants are requested 
to make their own travel and accommodation arrangements. 
October
5–7 October 2009
The Fifth European Association of Addiction 
Therapy Conference
Venue: Cankarjev Dom Cultural and Congress Centre, 
Ljubljana, Slovenia
Organised by / Contact: Cortex Congress Ltd, 20 Mortlake 
High Street, London SW14 8JN 
Tel: + 44 (0) 20 3287 7571
www.eaat.org/index.html 
Information: The European Association of Addiction 
Therapy (EAAT) has become one of the world’s leading 
conferences focusing on understanding the scientifi c 
and social bases of addiction. Each year the conference 
programme covers an extensive range of topics, including 
substance and non-substance addictions as well as the 
clinical, behavioural, social and environmental consequences 
of addiction. Attend EAAT 2009 to hear the latest research 
and opinions on a wide range of topics and issues, hear from 
leading experts, ask questions and debate with your peers.
8–9 October 2009
Getting a Grip 2009
Venue: Hotel Europe, Killarney
Organised by / Contact: Chris Barrow, 
Conference organiser
Email: lifeed@eircom.net
Information: Further information shortly on 
www.kerrylifeeducation.com 
19–21 October 2009
Recovery Careers: the quality of care and life. 12th 
International EWODOR Symposium
Venue: University of Stirling, Scotland
Organised by / Contact: European Working Group on 
Drugs Oriented Research / Convenor: Rowdy Yates, Dept of 
Applied Social Science, University of Stirling
Tel: + 44 (0) 1786 - 467737
Email: p.r.yates@stir.ac.uk 
www.dass.stir.ac.uk/old-site/ewodor
Information: In current substance abuse treatment, post-
modern concepts such as quality of care and life aftercare 
are clearly linked to recovery careers. Former and current 
users of treatment facilities depend for their recovery on the 
quality of the treatment system and ongoing support in the 
world around them. The programme of the symposium will 
not only examine the story of the crisis and rejuvenation of 
the European therapeutic community movement but will 
also explore the ideological and methodological background 
to this remarkable development. More importantly, the 
symposium will consider the successful life careers of former 
users and examine what can be learnt from quality of care 
and life research in other fi elds. The symposium will contain 
a mix of plenary presentations, panel discussions and 
workshop sessions.
November
5 November 2009
Irish Needle Exchange Forum National Conference
Venue: Malton Hotel, Killarney, Co Kerry
Organised by / Contact: Tim Bingham, Irish Needle 
Exchange Forum 
Email: tim@inef.ie
www.inef.ie 
Information: Speakers will include:
Jamie Bridge: Programme manager for the International 
Harm Reduction Association and co-deputy chair of the UK 
National Needle Exchange Forum
Dave Gordon: Team co-ordinator of a harm-reduction unit 
in Southampton
Josie Smith: Chairperson of All Wales Needle Exchange 
and research scientist with National Public Health Service 
for Wales
Mary O’Neill: Has a background in public health nursing and 
worked in the HIV /Drug services at the Baggot Street clinic. 
Currently works in the HSE Midlands as project manager in 
sexual health.
Tony Duffi n: Director of the Ana Liffey Drug Project 
Martin Chandler: Manager of the Inter Agency Drug Misuse 
Database at the Centre for Public Health in Liverpool John 
Moores University 
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The Alcohol and Drug Research Unit (ADRU) of the Health Research Board is a multi-
disciplinary team of researchers and information specialists who provide objective, reliable 
and comparable information on the drug and alcohol situation, its consequences and 
responses in Ireland. 
The ADRU maintains two national drug-related surveillance systems and is the national 
focal point for the European Monitoring Centre for Drugs and Drug Addiction. The unit also 
manages the National Documentation Centre on Drug Use. 
The ADRU disseminates research fi ndings, information and news through its quarterly 
newsletter, Drugnet Ireland, and the HRB series publications. Through its activities, the ADRU 
aims to inform policy and practice in relation to drug and alcohol use.
Drugnet Ireland is 
published by:
Alcohol and Drug 
Research Unit
Health Research Board
Knockmaun House
42–47 Lower Mount Street
Dublin 2
Tel: + 353 1 2345 127
Email: adru@hrb.ie
Managing editor: 
Brian Galvin
Editor: Joan Moore
11–12 November 2009
Research–Teaching Linkages: Practice and Policy
Venue: Trinity College Dublin
Organised by / Contact: National Academy for 
Integration of Research & Teaching & Learning 
(NAIRTL)
www.nairtl.ie/conference
Information: The 3rd annual NAIRTL conference 
focuses on best practice in the development of 
research-teaching links, identifying potential 
policy supports to help shape those links. The 
programme will feature keynote talks, invited 
papers, workshops and poster sessions. See 
website listed above for further details and free 
online registration. 
12–13 November 2009
Society for the Study of Addiction: Annual 
Symposium 2009
Venue: Park Inn, York, UK
Organised by / Contact: Society for the Study of 
Addiction / Graham Hunt, Leeds Addiction Unit 
Email: graham.hunt@leedspft.nhs.uk
www.addiction-ssa.org
Information: The themes of the 
symposium include:
Treatment policy
Service-user involvement
Young people and families
Professor Christine Godfrey will give the Society 
Lecture – ‘Addiction Treatment - Do economists 
contribute to the policy debate?’
Alcohol Education & Research Council 
Symposium: What does the AERC do?
March 2010
15–16 March 2010
4th Annual Conference of the International 
Society for the Study of Drug Policy
Venue: Santa Monica, USA
Organised by / Contact: RAND Drug Policy 
Research Center and UCLA’s Integrated 
Substance Abuse Program
www.issdp.org/conferences.htm 
Information: The theme of the conference 
is ’The future of drug policy: trends in policy, 
research to practice and practices that should 
be researched’. The conference should be of 
interest to policy makers, practitioners and 
academics from a wide array of disciplines who 
are engaged in drug policy analyses pertaining 
to drug markets, the harms caused by both 
the supply of and demand for drugs, and 
the intended and unintended consequences 
of policy. Researchers and/or practitioners 
interested in contributing papers that advance 
future thinking regarding the development, 
assessment, or evolution of drug policy 
nationally or internationally are encouraged to 
submit abstracts or panel sessions.
Upcoming events  (continued)
Improving people’s health through research and information
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